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INTRODUCTION 
Human tissues are well-organized systems. They consist of thousands of smaller 
functional modules, which all have crucial parts to play to achieve faultless 
functioning of the body. In order to understand how our body works one has to 
break the system down into small units, investigate them individually and try to 
merge the results into a big picture. The smallest functional unit in the body is a 
cell. This is why we tend to think of cells as the key building blocks of living 
systems. However, equally important are extracellular components, which by 
virtue of being arranged into elaborate systems allow cells to function properly 
and perform organ-specific tasks. 
In the present study, the focus is on skin tissue, where cells and extracellular 
structures exhibit an extensive network of interactions and a well-organized 
structure (Figure 1). 
  
 
 
Figure 1. Scanning electron microscopy (SEM) imaging of adult’s whole skin tissue 
(by Paula Reemann and Triin Kangur). SEM image shows layers and structural com-
ponents of the skin: cross-section of the epidermis and dermis (A), hypodermis (B), 
fibrillary proteins in dermis (C), magnification of collagen fibres (D). 
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The beauty of the skin structure has fascinated me for a long time and has 
inspired me to study the workings of this intricate system. It also raised the 
question, whether it can be mimicked artificially in order to provide some relief 
for the problems caused by the limited amount of donor skin. 
Studies linked to the current dissertation began with harvesting and des-
cribing the most common cell types of the skin – keratinocytes, melanocytes 
and fibroblasts. We sequenced the transcriptomes of cultured keratinocytes, 
melanocytes, fibroblasts and whole skin biopsies. The purpose of this study was 
to extend the existing knowledge about the background and functioning of these 
three skin cell types, often used for tissue engineering purposes. 
We took a detailed look at interleukin-10 family cytokines and their receptor 
expression in the skin as one of the most important aspects in tissue engineering 
is to avoid immunological responses, which interfere with regeneration and 
cause rejection of grafts. A number of IL-10 family cytokines have both pro-
inflammatory and anti-inflammatory roles, they can improve the healing process 
in injured skin, limit infection-induced damage or modify inflammation 
(Ouyang et al., 2011). Our study identified specific cytokine expression profiles 
for each cell type studied, and helped to explain the roles of different cells in the 
regulation of inflammatory response in the skin. 
Tissue-engineered products make extensive use of juvenile skin cells due to 
their excellent proliferative capacity. For the same reason we used juvenile 
fibroblasts to investigate the biocompatibility of novel sol-gel silica surfaces. 
Next, we studied glucose cross-linked fibrous gelatin scaffolds, which were 
found to possess favourable mechanical properties for skin tissue engineering 
purposes. Cultivation of juvenile fibroblasts on these matrices had significant 
impact on the proliferation and morphology of the cultured cells suggesting 
their enhanced biocompatibility when compared to conventional monolayer cell 
culture. 
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REVIEW OF LITERATURE 
1. Skin structure 
Skin is the largest organ of human body and constitutes about 15–20% of the 
body's total mass (Gartner and Hiatt, 2001). Skin is defined as an organ because 
it has different tissues that work together to perform its specific functions. Four 
main tissue types can be found in the skin – (a) different epithelial tissues 
(keratinized stratified squamous epithelium such as epidermis; simple squamous 
epithelium as endothelium in blood vessels; glandular epithelium and simple or 
stratified cuboidal epithelial cells in sweat gland; glandular epithelium and 
cornifying squamous epithelium in sebaceous gland; hair follicle epithelial 
cells), (b) extracellular matrix-rich connective tissues (dense irregular connec-
tive tissue such as dermis; loose connective tissue in blood vessels and nerves; 
fat tissue; blood and immune system cells), (c) nerve tissue (bundles of axons 
which form peripheral nerves and are connected to variety of sensory and motor 
nerve endings like free nerve endings, Merkel's cells, Meissner's corpuscles, 
Pacinian corpuscles, Ruffini endings and hair follicle receptors), and (d) muscle 
tissue (smooth muscle incorporated in the walls of the arterioles and erectors of 
hairs) (Burgdorf et al., 2009, Arend et al., 1994, Alberts et al., 2008, Gartner 
and Hiatt, 2001). 
At the same time the term “skin tissue” is very often used in literature. 
Usually it refers to two most prominent tissue layers in the skin: the outer epi-
dermis with keratinocytes and melanocytes and the deeper dermis with fibro-
blasts and extracellular matrix. A hypodermis below the dermis, which is 
composed of subcutaneous adipose tissue, is occasionally also encompassed by 
this term (Burgdorf et al., 2009). 
In the present study we use the term “skin tissue” to incorporate all three 
layers: epidermis, dermis and hypodermis and concentrate mostly on the three 
main skin cell types: keratinocytes, melanocytes and fibroblasts and the extra-
cellular matrix of the dermis. 
 
 
1.1. Epidermis 
Epidermis is a cell-dense, but relatively thin skin layer: in most of the body 
parts it is 70μm – 1.2mm (except palms and soles (Gartner and Hiatt, 2001)). 
Despite this, the undamaged epidermis prevents most infectious agents and 
harmful substances from entering the body. The epidermis has several layers 
(Figure 2) – (a) stratum corneum, composed of dead keratinized cell sheets, (b) 
stratum granulosum, a keratinized stratified squamous epithelium, (c) stratum 
spinosum, consisting of polygonal cells, where keratinization begins and (d) 
stratum basale (basal layer), which consists of mitotic cells (keratinocyte stem 
cells) which are attached to the basement membrane (Gartner and Hiatt, 2001). 
After division, the daughter keratinocytes start to migrate upward towards the 
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surface of the skin. The outermost layer of the skin consisting of dead cells 
constantly sheds off (Gartner and Hiatt, 2001), therefore, keratinocytes are 
responsible for the continuous renewal of the skin. Pigment producing melano-
cytes and antigen-presenting Langerhans cells, which detect foreign substances 
are located between the basal keratinocytes (Gartner and Hiatt, 2001). 
 
 
Figure 2. Schematic illustration of epidermis and dermis (based on Garter and Hiatt 
(Gartner and Hiatt, 2001) and Young and Heath (Young and Heath, 2000)). 
 
 
1.2. Dermis 
The thickness of dermis is approximately 0.6–3 mm, depending on the body site 
(Gartner and Hiatt, 2001). As it is not sharply demarcated from underlying 
hypodermis, the exact thickness is difficult to determine. The dermis consists of 
two functional layers of connective tissue: the superficial papillary layer and the 
deeper reticular layer, again without a clear margin between them (Gartner and 
Hiatt, 2001). The papillary layer is relatively thin, forming invaginations into 
the epidermis (dermal papillae). Compared to the reticular layer, it is more cell-
dense (Janson et al., 2012) and contains mainly fine collagen type III (less than 
5 μm) (Geneser, 1986) intertwined with fine elastic fibres. It also contains small 
blood and lymph vessels and nerves. The reticular layer of the dermis is relati-
vely thick, containing irregularly orientated collagen (mainly type I) fibres (5–
10 μm) (Geneser, 1986), which arrange into bundles (up to 100 µm) (Geneser, 
1986) and coarse elastic fibres (Sorrell and Caplan, 2004, Gartner and Hiatt, 
2001). It also contains large vascular plexus, lymph vessels and nerves pene-
trating the reticular dermis. 
The main cell type in the dermis is the fibroblast, but as in epidermis, cells 
from the other structures penetrating the skin tissue are also present: perineural 
Schwann cells, endothelial cells of blood vessels, some adipocytes, macro-
phages, mast cells etc. (Gartner and Hiatt, 2001). 
Stratum corneum
Stratum granulosum
Stratum spinosum
Stratum basale
Langerhans cell
Melanocyte
Papillary dermis
Reticular dermis
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1.3. Hypodermis 
Hypodermis (subcutaneous) is thickest layer of the skin. It invaginates into the 
dermis and is mainly formed by adipose cells held together by fibrous tissue. 
Each adipocyte is encircled by small capillaries, which bunch together to form 
bigger arteries and veins locating in the major fibrous septa (Gartner and Hiatt, 
2001). 
 
2. Skin cells 
Keratinocytes and fibroblasts form the main cellular mass in the skin (7×105 – 
9×105 keratinocytes per mm2 (Bauer et al., 2001, Hoath and Leahy, 2003) and 
2×103 mid-dermis fibroblasts (Miller et al., 2003) to 105 papillary fibroblasts per 
mm3 (Randolph and Simon, 1998). The average number of pigment-producing 
melanocytes depends on the body site and is estimated to be between 500 to 2000 
melanocytes per mm2 (Gartner and Hiatt, 2001, Thingnes et al., 2012). 
Keratinocytes make up the majority of the cellular mass (95%) of the 
epidermis (Haake et al., 2001) and they have several roles in a mammalian 
organism. They form a hydrophobic envelope acting as a mechanical barrier 
against external pathogens. Keratinocytes secrete different kinds of cytokines 
and signal molecules, thereby modulating immunological and regenerative 
status of the skin (Burgdorf et al., 2009). Additionally, they keep other epider-
mal cells in place. 
Another important cell type in the epidermis is the pigment-producing 
melanocyte. These cells are located on the basement membrane together with 
keratinocyte stem cells. It is estimated that there is one melanocyte per five to 
six basal keratinocytes in the basal layer (Park et al., 2012). Melanocytes are 
highly influenced by surrounding keratinocytes, which regulate melanocyte 
survival, dendricity, melanogenesis, and the expression of cell surface receptors 
(Park et al., 2012). Individual variation in the melanocyte number is remarkably 
small (Gartner and Hiatt, 2001). Melanocytes are highly outnumbered by 
keratinocytes, which makes it difficult to study them in whole skin biopsies and 
increases the likelihood that their role in different pathological processes will be 
underestimated. Besides the pigment synthesis, melanocytes have both local and 
systemic functions: they are able to secrete a wide range of signaling molecules, 
e.g. proinflammatory cytokines, immunosuppressive molecules, neuromediators 
etc. (Slominski, 2009, Park et al., 2012). 
Fibroblasts constitute the majority of the cells in the middle layer of the 
skin – the dermis. Fibroblasts originate from mesenchymal stem cells and are 
normally found in many tissues (Arend et al., 1994). A dermal fibroblast differs 
from fibroblasts originating from other tissues by having less cellular plasticity: 
their reprogramming to other fibroblast types is far less likely. At least two 
subpopulations of dermal fibroblasts have been described: papillary and reti-
cular (Sorrell and Caplan, 2004). These are located in papillary and reticular 
dermis, respectively. These two cell populations have multiple differences at the 
gene expression level (Janson et al., 2012), in the production of factors that 
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regulate epithelial and mesenchymal cells interactions, cellular proliferation and 
extracellular matrix production (Sorrell and Caplan, 2004). In addition, they can 
be distinguished by morphology: reticular fibroblasts have more polygonal 
appearance, while papillary fibroblasts tend to be spindle-shaped (Janson et al., 
2012). Papillary fibroblasts are more proliferative than reticular fibroblasts 
(Azzarone and Macieira-Coelho, 1982, Janson et al., 2013, Harper and Grove, 
1979) and the loss of papillary fibroblasts might play a role in skin aging (Mine 
et al., 2008). 
 
 
3. The role of interleukin-10 (IL-10) family cytokines in 
defense mechanisms of the skin 
The most important roles of the skin are protection, sensation, thermoregulation 
and metabolism. Protection against pathogens and other harmful agents includes 
providing an impenetrable barrier to the outer world and the ability to control 
adequately immune and inflammatory responses to environmental factors. The 
IL-10 family cytokines are crucial players in host defense mechanisms. They 
can improve the healing process, limit infection-caused damage or modify in-
flammation by promoting innate immune responses in epithelial tissue (Mosser 
and Zhang, 2008, Cao et al., 2006, Sonnenberg et al., 2010). Recent results 
suggest that the IL-10 family of cytokines is involved in the function of skin as 
well as in the pathogenesis of major skin diseases (e.g. psoriasis and atopic 
dermatitis) (Mosser and Zhang, 2008, Ouyang et al., 2011) 
The IL-10 family includes a number of cellular cytokines: IL10, IL19, IL20, 
IL22, IL24, IL26, IL28A, IL28B, and IL29. This classification is based on 
distinctive six-alpha-helix structure that is common to all mature IL-10 family 
members (Trivella et al., 2010). They also share up to 28% of their amino acid 
level (Dumoutier and Renauld, 2002, Fickenscher et al., 2002). However, 
receptor-binding domains of IL-10 family cytokines are variable and define 
their interaction with different receptors (Ouyang et al., 2011, Sheppard et al., 
2003) (Table 1). 
 
Table 1. The interaction of IL-10 family cytokines with cytokine receptors. IL-10 
family cytokines have been shown to exert their function through different receptors by 
partly sharing receptor subunits or whole receptor complexes (Ouyang et al., 2011, 
Sheppard et al., 2003). 
 
Gene IL10 IL19 IL20 IL22 IL24 IL26 IL28B IL29 
IL10RA         
IL10RB         
IL20RA         
IL20RB         
IL22RA1         
IL22RA2         
IL28RA         
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The variability of the receptor affinities is likely to cause differences in the 
biological functions of these interleukins. All receptors of IL-10 family cyto-
kines (IL10RA, IL10RB, IL20RA, IL20RB, IL22RA1, IL22RA2 and IL28RA) 
belong to class II cytokine receptor family commonly composed of ligand-
binding alpha subunit and signal-transducing beta or gamma chain subunits 
(Ouyang et al., 2011, Langer et al., 2004). 
 
 
4. Extracellular matrix 
Cells are always interacting with surrounding structures in the living tissue – 
other cells, supporting structures, loose connective tissues etc. In multicellular 
organisms, cells are supported by the extracellular matrix (ECM). It is com-
posed of numerous proteins and polysaccharides, which are assembled into a 
scaffold (Alberts et al., 2008). The structure and mechanical properties of ECM 
are highly tissue-specific and provide the necessary environment for the cells. 
For example, in bone tissue the calcium-containing ECM is strong and provides 
mechanical support for the whole body, while in skin the ECM is elastic and 
stretchable (Alberts et al., 2008). The mechanical properties of the ECM dictate 
the mechanical properties of the whole tissue (Thomas et al., 2010) – the skin 
has an elastic modulus of 0.1–10 kPa, the brain 0.5 kPa and the muscle tissue 12 
kPa (Achterberg et al., 2014). The amount of ECM found in different organs 
also varies to a great extent. In the cartilage and bone, it is the major component 
of the tissue, but in the brain it is only a minor constituent (Alberts et al., 2008). 
Two forms of ECM are found in human tissues – stromal matrix and base-
ment membrane (Alberts et al., 2008). Both these structures are present in skin. 
The basement membrane is the most prominent ECM structure in the epidermis 
and separates the outer epidermis from the underlying dermis (Alberts et al., 
2008). Keratinocytes in the multilayered epidermis are closely linked to each 
other by a very complex interaction system, which is formed by specialized 
junctions (anchoring junctions, tight junctions and gap junctions) (Alberts et al., 
2008). Therefore, the extracellular spaces between keratinocytes are very 
narrow (Arend et al., 1994). Although the ECM between epidermal cells cannot 
be directly visualized by simple light microscopy, the intra-keratinocyte space is 
filled with hyaluronan (Tammi et al., 1988) and a small amount of proteo-
glycans (epican) and lipids (Comper, 1996, Arend et al., 1994). Nevertheless, 
speaking about the epidermal ECM, it usually comprises the basement 
membrane. 
The basement membrane is a highly organized structure and contains the 
following proteins – laminin, type IV and VII collagen, bullous pemphigoid 
antigens, entactin/nidogen and proteoglycans (perlecan, heparan sulfate family 
members) (Alberts et al., 2008, Krieg and Aumailley, 2011, Giudice et al., 
1993). It plays a crucial role in pathological processes such as wound healing 
and tumor cell or pathogen invasion (Alberts et al., 2008). 
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In epidermis, the cells (keratinocytes, melanocytes) are lined onto the ECM 
(basement membrane); in dermis, however, the cells (fibroblasts) are dis-
persedly embedded into ECM. The ECM of dermis is a mixture of numerous 
components such as fibrillary proteins (collagens, elastin), other proteins (fibro-
nectin, laminins, etc.) and more than 40 different proteoglycans (protein-linked 
polysaccharides) e.g. glycosaminoglycans (hyaluronan, chondroitin sulfate, 
dermatan sulfate, heparan sulfate, and keratan sulfate) (Alberts et al., 2008, 
Krieg and Aumailley, 2011). 
The fibrous components of dermal ECM form a continuous network where 
the predominant orientation of the fibres is parallel to the skin surface and 
follows Langer’s tension lines (Leesion et al., 1985). 
For many years the ECM was considered a relatively inert scaffold for the 
tissue and the cells were thought to play the most important role in the 
functioning and regeneration of the tissue. Now it is clear that the extracellular 
environment is actually much more active in regulating cell viability and tissue-
specific functioning. For instance, it is known that the ECM attracts sodium 
ions due to its high glycosaminoglycan content and is therefore crucial in 
regulating fluid balance in the body (Alberts et al., 2008). 
 
 
5. Skin grafting 
The management of patients with extensive skin defects resulting from burns, 
trauma, chronic wounds and congenital defects is a challenging situation in the 
clinic and often requires skin coverage or replacement. 
The use of autologous skin grafts (donor tissue from the same individual) 
goes back thousands of years whereas the first published scientific reports came 
from late nineteenth century (Aziz and Shushan, 2010). Both split-thickness 
skin graft, which includes the entire epidermis and a part of the dermis and full-
thickness skin graft, which involves all the layers of the skin are nowadays in 
clinical use. Although autologous skin grafting yielded good results, the areas 
where the skin can be harvested are usually limited, especially in case of large 
burns. The alternatives to autologous skin grafting are the use of allograft 
tissues (tissue from the other individual, including cadaver) and xenografts (skin 
from other species) (Aziz and Shushan, 2010). Soon it became clear that the 
latter two approaches often caused graft rejection due to immunological 
incompatibility (Aziz and Shushan, 2010). In case of cadaver tissue the main 
issue is its limited availability. 
In the late 1970s, Rheinwald and Green began experimenting with creation 
of artificial skin that could be permanently grafted onto patients. It started with 
simple experiments where cells were isolated and seeded onto the damaged 
tissue site (Aziz and Shushan, 2010). Soon scientists began to realize that using 
only cells does not lead to sufficient skin replacement and a scaffold for 
forming the functional tissue is needed. 
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Now such medical devices, named “skin substitutes” are manufactured by 
seeding human cells onto a matrix containing proteins and growth factors, 
which simulate the cells to form a properly organized tissue (Altala et al., 2011). 
Despite decades of research on skin substitutes, we still face similar prob-
lems as in the beginning of skin grafting. Skin autografting is still the gold stan-
dard procedure and although skin substitutes are available there are still 
problems concerning immunological rejection. Furthermore, no dermo-epider-
mal skin substitute, which can fully mimic the natural environment, is available 
for clinicians to date. 
 
 
6. Skin substitutes 
Skin substitutes are used to improve wound closure, control associated pain, 
prevent excessive scar formation and facilitate functional skin tissue regene-
ration. An optimal skin substitute should provide one-step replacement and it 
should be produced in large-scale at a reasonable price. 
There are both permanent and temporary devices available (Altala et al., 
2011). A temporary dressing material protects against pathogens and water loss, 
acting as a simple mechanical barrier. Amniotic membrane, Oasis® (porcine 
small intestine wall), synthetic polymer sheet or sprays and also combined 
materials – Transcyte® (human fibroblast on silicon film) and Biobrane® 
(silicone-nylon mesh with porcine collagen) – are a few examples. These pro-
ducts protect the wound only for a short time and are meant to be peeled off 
when the wound has re-epithelialized. “Permanent” substitutes are used to 
replace the full thickness of skin layers for a longer period, but are usually fully 
or partially degradable by host tissues over the time. The permanent skin sub-
stitutes include EpiCel® (cultured epithelial autograft grown in the presence of 
proliferation-arrested mouse fibroblasts), Integra® (silicone with porous matrix 
of cow collagen and glycosaminoglycan), OrCel® (human keratinocytes and 
dermal fibroblasts, cultured in separate layers into a bovine collagen sponge). 
Dieckmann et al. have suggested that skin substitutes can be divided into two 
main categories: a) biomaterial and b) cellular (Dieckmann et al., 2010). Bio-
materials are acellular and produced from natural or synthetic sources. Natural 
skin substitutes are for instance human cadaver skin or decellularized bovine or 
porcine xenografts (e.g. Alloderm®, Strattice®), but also engineered tissue 
using biological materials including polypeptides, hydroxyapatites, glycos-
aminoglycans (including hyaluronan), fibronectin, collagen, chitosan and 
alginates, which all originate mainly from animal sources. Synthetic skin sub-
stitutes, which are made from various biodegradable and non-degradable combi-
nations of natural and synthetic polymers, are described in detail in the next 
paragraph. 
The majority of the clinically available skin substitutes are natural bio-
materials, which do not contain any cells. Only a few skin substitutes in clinical 
20 
use are tissue engineered and contain viable cells and either natural or synthetic 
extracellular matrix. 
Apligraf®, StrataGraft® and OrCel® are dermo-epidermal composite grafts, 
which contain fibroblasts and keratinocytes seeded into a combined collagen 
matrix. Similarly, epidermal substitute Epicel® contains human keratinocytes 
and proliferation-arrested mouse fibroblasts seeded onto nonporous silicon film. 
Dermal substitutes Transcyte® and Dermagraft® contain human fibroblasts, 
which are seeded onto bioabsorbable polyglactin mesh. 
Above-mentioned materials are the most popular commercially available 
skin/dermal substitutes, which are currently in clinical use (Zhang and 
Michniak-Kohn, 2012). US Food and Drug Administration (FDA) has specific 
regulations concerning skin substitutes of different origin and composition. The 
regulations concerning human cells and tissue products are applied on products 
derived from human materials, but additional and the most strict requirements 
have been set for products containing manipulated cells and tissues. For this 
reason, only a few such products are available on the market. 
These demanding needs and strict regulations have caused the researchers to 
focus on manipulating the subcellular environment (gene and protein expres-
sion, cell morphology etc.) and studying the responses of cells to the changes in 
nano- and microscale environment. 
 
 
7. Biomaterial surfaces 
The widely used definition for “biomaterials” given by the American National 
Institute of Health postulates them as substance or combination of substances 
(drugs not included), synthetic or natural in origin, which augments or replaces 
partially or totally any tissue, organ or function of the body and therefore 
interacts with living tissue. There are several possibilities to develop these 
biomaterials. A basic example is a biocompatible surface. Well-known examp-
les of biocompatible surfaces are the different coatings for bone or joint metal 
implants where interactions with the surrounding tissue are crucial (Altala et al., 
2011). The advanced form of biomaterial is a bioactive or biofunctional surface, 
which can improve the adhesiveness or interaction between cells and sur-
rounding environment. This can be achieved by using different nanoscale pat-
terns, adding chemical groups or organic/inorganic compounds to natural matrix 
components, modifying hydrophility of the biomimetic surfaces etc. Finally, 
there are biomimetic materials, which are inspired by specific properties of 
natural structures. 
Sol-gel technique has been shown to be suitable for designing the nano- and 
microstructure of surfaces with various mechanical properties as well as 
chemical composition and functionality (Dirè et al., 2011, Saal et al., 2011). 
Sol-gel approach is based on the hydrolysis and polymerization reactions of 
silicon and metal alkoxides. 
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SiO2 has been widely used in bone tissue engineering for enhancing 
adhesion between bone cells and for preventing the formation of non-adherent 
fibrous capsule around the implant (Hollinger, 2011). Different production 
methods of SiO2 result with different properties of the material (Hollinger, 
2011). Biocompatible glass surfaces are conventionally produced by melting. 
This technique produces a dense surface with minimal porosity whereas sol-gel 
method allows fabrication of thin film coatings, different nanoparticles, porous 
materials and fibres. Sol-gel polymerization of tetraethylorthosilicate 
(Si(OC2H5)4; TEOS) is a well established and widely used method of producing 
silicon dioxide: Si(OC2H5)4 → SiO2 + 2 (C2H5)2O. In the present work we have 
applied a novel sol-gel phase separation-based synthesis for designing micro- 
and nanopatterned surfaces with structural biofunctionality. In this method, 
silicon alkoxide domains are nucleated in continuous liquid phase, leading to 
the formation of dome-shape silica micro- and nanostructures on a substrate as 
the liquid phase is removed. Silicon alkoxide condensates into gel and silica 
surface features are formed after ageing and thermal treatment. This method 
produces round patterns and therefore represents a more biomimetic approach 
compared to edged nano- and micropatterns obtained by conventional litho-
graphy methods. 
 
 
8. The design of extracellular matrix 
The manufacturing of artificial organs depends on our ability to prepare a 
suitable scaffold, which mimics the structure of the specific tissue and sustains 
the characteristic properties of the cells, which are necessary for this particular 
tissue to function (Altala et al., 2011). Taken together, this artificial scaffold 
should provide all the functions of the extracellular matrix of the particular 
tissue. 
The ideal matrix for skin substitute should: (a) enhance interaction of the 
matrix and host tissue, (b) mimic natural skin structure, (c) permit diffusion of 
nutrients, gases and growth agents to supply the cells, (d) provide support for 
adhesion, promote proliferation and tissue-specific functioning, (e) lack immu-
nogenicity and toxicity, (f) possess controllable biodegradability. 
Thus, choosing proper biomaterials is a crucial step in the development pro-
cess. A wide range of synthetic and natural materials has been reported. 
 
 
8.1. Polymers 
As a raw material source, synthetic polymers usually possess superior stability – 
their shape, size, nanostructure, porosity, mechanical and chemical properties 
are easily reproducible and they are also less expensive than natural materials 
(Place et al., 2009). A number of different synthetic polymers have been 
reported as suitable materials for skin tissue engineering. The studies using 
synthetic polymers for skin substitutes concentrate on two main sub-classes – 
22 
degradable (polylactide (PLA), polyglycolide (PGA), poly-lactic-co-glycolic 
acid (PLGA), polycaprolactone (PCL)) and non-degradable (polytetrafluoro-
ethylene (PTFE), polyethylene terephthalate (PET), polypyrrole (PPy), poly-
urethane PU)) materials (Place et al., 2009, Altala et al., 2011). The non-
degradable materials are mainly used as temporary dressing for wounds. Poly-
urethane and nylon are the two most widely and extendedly used synthetic 
materials, which have proven to be highly tolerated by human organism (e.g. 
surgical dressings and sutures). PTFE is the basic ingredient in several implants 
of blood vessels and heart valves (Altala et al., 2011). 
An alternative approach to fully synthetic skin substitute is to polymerize or 
co-polymerize naturally occurring metabolites into larger molecules. Such poly-
mers are degraded after a certain time period into compounds normally present 
in our body. For example, lactide and PLGA are converted into lactic acid and 
glycolic acid – the by-products of several metabolic pathways in the body. 
Degradable and non-degradable polymers can be combined into scaffolds with 
novel mechanical and chemical properties and, as a result, the material 
previously characterized as non-degradable might become partially or fully 
degradable like in the case of PPy-PLA combination (Shi et al., 2004). 
Natural polymers can interact with cells and modulate their biological 
activity due to their nature as biologically active molecules. For example, 
synthetic materials, which are initially produced as static scaffolds can be mo-
dulated by surface reactions promoting the bonding of the materials with 
surrounding tissue (e.g. bioactive glass) (Altala et al., 2011). 
 
 
8.2. Natural polymers. Gelatin. 
Natural macromolecules, mainly proteins (collagens, gelatin, elastin, silk, fibri-
nogen, keratin, actin, myosin) and polysaccharides (glycosaminoglycans, chito-
san, cellulose, amylose, dextran) have in many cases been used for skin 
engineering (Altala et al., 2011). 
Gelatin is a mixture of proteins and polypeptides derived by hydrolysis of 
collagen, a naturally occurring protein, which is the most abundant protein of 
the extracellular matrix in connective tissue (Gorgieva and Kokol, 2011). Both 
collagen and gelatin have been widely used in tissue engineering scaffolds. 
Approximately 30 types of collagens have been described. In the skin, collagens 
are largely secreted by fibroblasts, but can also originate from other cells 
(Alberts et al., 2008). Collagen is the major component of skin and bone, 
constituting up to 25% of the total protein mass of the body (Alberts et al., 
2008). Collagen is usually purified from animal tissues (swine, bovine) and its 
properties have been well examined. It has proven to be biocompatible, non-
toxic and biodegradable material, which is very good at supporting cell growth. 
Therefore, numerous forms of collagen have been designed – coatings, sheets, 
beads, capsules, meshes, fibres, sponges etc. (Gorgieva and Kokol, 2011). 
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However, there are certain disadvantages of using collagen derived from 
natural sources, such as poor stability (swelling and contraction in vivo) and 
poor resistance to mechanical loading. 
Compared to collagen, gelatin is less prone to evoke immune responses due 
to the absence of aromatic groups found in collagen (Gorgieva and Kokol, 
2011). Gelatin is a mixture of several proteins and their fragments and its main 
constituent is type I collagen (Gorgieva and Kokol, 2011), which was also 
confirmed in our study (Table 7). The exact composition of gelatin depends on 
the extraction method as well as the origin of the raw material (Gorgieva and 
Kokol, 2011). Gelatin hydrates in aqueous environment and is fully degradable 
in vivo (Gorgieva and Kokol, 2011). To overcome the problems with stability 
and durability of this material and also to reduce swelling, cross-linking of 
gelatin chains is used. Cross-linking decreases solubility by creating chemical 
bonds between polymer chains (Gorgieva and Kokol, 2011). 
Several cross-linking techniques have been described – chemical methods 
(using dialdehydes, phenolic compounds, genipin etc. (Zhang et al., 2010, 
Panzavolta et al., 2011, Gorgieva and Kokol, 2011), enzymatic (Bertoni et al., 
2006) and physical methods (UV, temperature) or a combination of these 
(Gorgieva and Kokol, 2011, Birshtein and Tulchinskii, 1982). However, a large 
proportion of chemical cross-linkers are toxic to a varying degree and therefore 
their use is limited in tissue engineering application (Gorgieva and Kokol, 
2011).  
In our study we used a combination of glucose and thermal cross-linking, 
which results in a higher extent of covalent bounds between gelatin molecules 
and thereby provide better mechanical stability to the material. Additionally, 
glucose in the physiological range is non-toxic and is naturally used in the body 
as a cross-linker. 
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AIMS OF THE STUDY 
The purpose of this study was to design novel biocompatible materials for the 
skin tissue engineering and to evaluate the suitability of these materials with 
different physical and chemical properties for the growth of primary cells 
isolated from human skin. 
The specific aims of the study were to: 
1. Describe the expression of interleukin-10 family cytokines and their 
receptors in keratinocytes, melanocytes and fibroblasts in order to describe 
their inflammatory and healing potential. 
2. Characterize the main cell types in the skin – keratinocytes, melanocytes and 
fibroblasts by gene expression profiling. 
3. Evaluate the effects of micro- and nanopatterned silica surfaces on fibroblast 
viability and morphology. 
4. Investigate the biological properties of a novel biomimetic extracellular 
matrix for skin. 
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MATERIALS AND METHODS 
1. Human subjects (Papers I–IV) 
In our study, we used 25 pediatric foreskins obtained from healthy circumcised 
patients (aged 5 months to 10 years) and punch-biopsies from 15 healthy adult 
volunteers (aged 19 to 79 years). Pediatric patients were recruited from elective 
patients present at the Department of Pediatric Surgery, Tallinn Children’s 
Hospital. Adult volunteers were recruited from patients attending the outpatient 
clinic of the Department of Dermatology of the University of Tartu. All 
procedures were carried out in accordance with the ethical standards. This study 
has been approved by Research Ethics Committee of the University of Tartu 
(approval number 178/T-19). 
A written informed consent (approved by Research Ethics Committee of the 
University of Tartu) was obtained from all adult volunteers and from all parents 
or caretakers of patients under 18 years. Additionally, a separate written in-
formed consent was obtained from all patients aged 8–17 years. 
We only used circumcised tissue samples from healthy children with no 
concurrent diseases and signs of infection. Pediatric tissue samples were by-pro-
ducts of circumcision procedures and no additional intervention was incurred. 
One biopsy sample (ø 4 mm) from non-sun-exposed skin was taken from a 
healthy adult volunteer with no concurrent diseases. 
All samples were coded and information of the donor identity was only 
available to the physician. All patient related information was stored separately 
from the samples and the data. Schematic diagram of sample processing in the 
study can be found on Figure 3. 
 
 
 
Figure 3. Schematic diagram of sample processing in the study. 
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1.1. Tissue samples 
0.9% NaCl solution was used to stabilize the juvenile samples during the 
transport to the laboratory at 4oC. Pediatric tissue was divided into two parts. 4–
5 mm3 piece was transferred into RNALater (Life Technologies) for RNA 
extraction and the remaining tissue part used for extraction of cells. Adult 
biopsy samples were instantly frozen in liquid nitrogen and stored at 80oC until 
RNA extraction. Samples for immunohistochemistry were instantly inserted 
into 10% formalin for fixation. One adult biopsy sample was fixed in Kar-
novsky fixative for scanning electron microscopy. 
 
2. Isolating and growing skin cells (Papers I–IV) 
We isolated keratinocytes, melanocytes and fibroblasts from pediatric foreskins. 
Skin pieces were rinsed in phosphate-buffered saline (PBS, without Ca, Mg, 
PAA Laboratories GmbH). Subcutaneous fat was removed and tissue was 
incubated in dispase II (2.4 U/ml in PBS, Sigma-Aldrich) at 4oC overnight. 
Epidermis as a source of keratinocytes and melanocytes was peeled off from the 
dermis, transferred into 0.05% trypsin-0.02% ethylenediaminetetraacetic acid 
(EDTA) (Life Technologies) for 3 min at 37°C. Enzymatic process was stopped 
with trypsin inhibitor (Sigma-Aldrich). Cell suspension was divided into two 
parts – one for the isolation keratinocytes and the other for the isolation of 
melanocytes. 
We used cell-specific selective media to isolate a particular cell type: 
EpiLife® basal medium with human keratinocyte growth supplement (Life 
Technologies) for keratinocytes and growth medium M2 with supplement mix 
(PromoCell) for melanocytes. Melanocyte culture dishes were precoated with 
gelatin. 
The remaining piece of dermis was used for isolation of fibroblasts via 
migration method. The dermis was rinsed in PBS, cut into approximately 4x4 
mm pieces and attached onto a culture dish, covered with 10 ml of Dulbecco's 
Modified Eagle's medium (DMEM) (PAA Laboratories GmbH) with 10% foetal 
bovine serum (FBS, Sigma-Aldrich), penicillin (100 UI/ml), streptomycin (100 
μg/ml) (PAA Laboratories GmbH) and amphotericin B 250 ng/ml (Sigma-
Aldrich; added only at the isolation step). The media were changed every 
second day throughout the study. 
The subculture (passage) of cells was done with 65–70% (in case of kera-
tinocytes) and with 80–95% (in case of melanocytes and fibroblasts) cellular 
confluence in the Petri dish. Cells with passage number 2–3 were used for 
subsequent isolation of RNA. The remaining cells were cryopreserved in 10% 
dimethyl sulfoxide (DMSO, Sigma-Aldrich) diluted in FBS upon on-demand 
usage. Prior to usage on designed surfaces, growth curve was determined at 
different densities to obtain optimal seeding density of the cells. 
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2.1. Lipopolysaccharide stimulation 
Reaching approximately 90% confluence, melanocytes and fibroblasts were 
incubated in lipopolysaccharide (LPS) (E. coli 0111:B4, Sigma-Aldrich) and 
media solution (10 ng/ml) for 12 h and with media alone (controls). After 
treatment, the cells were washed with PBS and used for the isolation of RNA 
for qRT-PCR. 
 
 
3. RNA extraction (Papers II, IV) 
3.1. RNA extraction for whole transcriptome sequencing 
The skin cells underwent lysis and RNA extraction process using Trizol 
(Invitrogen) and RNeasy mini columns (Qiagen) combined protocol. 
The tissue samples were homogenized using Precellys 24 system and total 
RNA was isolated from tissues with RNeasy Fibrous Tissue Mini Kit (Qiagen) 
according to the manufacture’s protocol. 
Extraction of RNA for whole transcriptome sequencing was performed 
accompanied with DNAse I (Qiagen) treatment. The purity and concentration of 
samples was checked with both Qubit spectrophotometer and Nano Drop ND-
1000 and the integrity of the RNA (RIN) was evaluated using Agilent 2100 
Bioanalyzer. 
 
3.2. RNA extraction for qRT-PCR 
The skin cells underwent lysis and RNA extraction process using Trizol 
(Invitrogen) and RNeasy mini columns (Qiagen) combined protocol. The skin 
biopsies were homogenised using T10 basic homogeniser (IKA Labortechnik) 
and total RNA was isolated from tissues with RNeasy Fibrous Tissue Mini Kit 
(Qiagen) according to the manufacture’s protocol. The RNA content and quality 
was determined by spectrophotometry (Nano Drop ND-1000). 
 
 
4. Whole Transcriptome sequencing (Paper IV) 
We chose 12 total RNA samples, with the highest RIN (9–10), extracted from 
four keratinocyte, four melanocyte, two fibroblast and two whole skin samples 
for library preparation. Extracted RNA was enriched using RiboMinusTM 
Eukaryote kit (Invitrogen) according to the manufacturer’s instructions. The 
final quantity of RNA was 10 µg per reaction. The cDNA library was size-
selected in the range of 150–250 bp and bar-coded according to a protocol 
provided by Applied Biosystems. Samples were sequenced using SOLiD 
5500xl platform with 75 bp forward and 35 bp reverse primers. 
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5. Gene expression analysis by qRT-PCR (Paper II) 
Approximately 500 ng of each RNA sample was used to synthesize cDNA 
using High Capacity cDNA Reverse Transcription Kit (Life Technologies) 
according to the manufacturer’s protocol. Gene expression was detected using 
qRT-PCR (7900 Fast QRT- PCR, Life Technologies. Two primers exon 6 (5’-
GACTTTGCTTTCCTTGGTCAGG-3’) and exon 7 (5’-AGTCTGGCTTA 
TATCCAACACTTCG-3’) and labelled probe (VIC-5’-TTTCACCAGCAAG 
CTTGCGACCTTGA-3’-TAMRA) were used to detect the mRNA expression 
level of the reference gene hypoxanthine phosphoribosyl-transferase-1 (HPRT-
1). Expression levels of other genes under investigation were detected using the 
following 20x probe assays (Life Technologies): IL10 (Hs00174086_m1), 
IL10RA (Hs00155485_m1), IL10RB (Hs00175123_m1), IL19 (Hs00203540_ 
m1), IL20 (Hs00218888_m1), IL22 (Hs00220924_m1), IL20RA (Hs00205346_ 
m1), IL20RB (Hs00376373_m1), IL22RA1 (Hs00222035_m1), IL22RA2 
(Hs00364814_m1), IL24 (Hs00169533_m1), IL26 (Hs00218189_m1), IL29 
(Hs00601677_g1), IL28RA (Hs00417120_m1) and IL28B (fw 5’-AGAGGG 
CCAAAGATGCCTTAG-3’, rv 5’-GGGAGCGGCACTTGCA-3’, FAM-5’-
AGAGTCGCTTCTGCTG-3’- MGB). 
 
 
6. Immunohistochemistry (Paper II) 
Skin tissue samples (n=5, both juvenile and adults) were fixed in 10% formalin 
for 24 h and embedded in paraffin. Deparaffinized sections were treated with 
3% H2O2 followed by REAL Antibody Diluent (Dako) to block non-specific 
binding. After blocking, sections were incubated with rabbit polyclonal 
antibody to IL29 (ab38569) 1:100, IL28 receptor alpha (ab83865) 1:200, IL22 
RA2 (ab96341) 1:500, IL26 (ab102977) 1:200 or IL10RB (ab106282) 1:200 
overnight at 4°C (all antibodies were purchased from Abcam Ltd.). Visuali-
sation of the primary antibodies was performed by using REALTM EnVisionTM 
Detection System (Dako). The washing steps were carried out with PBS 
containing 0.07% of Tween 20. Thionine blue (Sigma-Aldrich) was used for 
background staining. No immunohistochemical staining was noted in negative 
controls where the primary antibody was omitted. 
 
 
7. Fibroblast cultivation on sol–gel prepared 
nanopatterned silica surfaces (Paper I) 
7.1. Preparing silica structures 
Patterned substrates were prepared from solutions of partially hydrolyzed 
tetraethylorthosilicate (TEOS) in different solvents (propanol, methanol, ethanol 
and hexane). All chemicals were purchased from Sigma-Aldrich. Conventional 
acid-catalyzed hydrolysis and polymerization of TEOS was carried to prepare 
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sols on 12 mm borosilicate glass cover slips. The corresponding used sols were: 
TEOS:propanol = 1:5 (resulting samples are referred to as S1 below); TEOS: 
ethanol = 1:5 (S2); TEOS:methanol = 1:2 (S3); TEOS:methanol = 1:5 (S4). 
Spin coating resulted in the formation of patterns of different size nano- and 
micro-domes. For a reference sample, smooth silica surfaces were prepared 
from a sol: TEOS:hexane = 1:10 (Smooth). All samples were subsequently 
heated at 200 °C for 20 h to transform gel material into oxide. The preparing 
process of the silica structures has been described in more detail in Paper I. 
 
 
7.2. Atomic force microscopy 
For investigating the morphology of structured surfaces, atomic force micro-
scope (AFM) images were obtained with Dimension® Edge™ AFM System 
(Veeco Instruments Inc.) in tapping mode at room temperature. Height of the 
surface features was estimated by using the Gwyddion 2.30 software. AFM 
imaging was performed by Triin Kangur. 
 
 
7.3. Fibroblast cultivation on silica structures 
Previously isolated and cryopreserved fibroblasts were resuspended in a fresh 
culture medium (DMEM) and cultivated for 1–3 days. Cells were seeded onto 
nanopatterned cover slips and a flat borosilicate glass (12 mm diameter) at 
density of 3,000 cells/cm2 in a 24-well plate for antibody and SA-b-gal staining 
and 10,000 cells/cm2 for scanning electron microscopy. 
 
 
7.4. Fluorescent microscopy 
Ki67 and γ-actin staining was performed on the fifth day of culture. For actin 
antibody staining, fibroblasts on glass and nanopatterned coverslips were briefly 
washed with PBS followed by fixation in cold methanol (Naxo) and acetone 
(POCH), both for 5 min. For Ki67 antibody staining the cells were fixed with 
3.7 % formaldehyde (Scharlab) in PBS for 7 min at room temperature. Fixed 
tissues were rehydrated, washed with PBS/0.25 % Triton X-100-PBS and 
blocked for 1 h with PBS/Triton X-100-PBS containing 5% normal donkey 
serum (Jackson ImmunoResearch Inc.). Incubation with mouse monoclonal 
IgG1 anti-γ-actin primary antibody (Santa Cruz Biotechnology Inc.; 1:200) and 
Ki67 rabbit monoclonal antibody (Epitomics Inc.; 1:500) was performed in 2% 
blocking solution for 45 min at room temperature and overnight at 4 °C. After 
washing, the slides were incubated with Alexa Fluor® 488-labelled donkey 
anti-mouse IgG (H + L) secondary antibody and Alexa Fluor® 594-labeled 
donkey anti-rabbit IgG (H + L) secondary antibody (both 1:500, Life Techno-
logies), respectively. Nuclei were counterstained with DAPI (AppliChem;  
1 lg/ml), followed by washing in PBS and ultra pure water and mounting in 
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fluorescence mounting medium (Dako). Immunofluorescence microscopy was 
carried out with an Olympus FluoView FV1000 microscope, with a 60x 
objective and images were acquired with Olympus FV10-ASW 1.6a software. 
For counting of adhered cells, Zeiss Axiovert S100 inverted microscope with 5x 
and 10x objectives and AxioVision Rel. 4.8.2, software were used. Typically, 
data was collected from four randomly chosen fields from four cover slips. 
Images were analyzed with ImageJ 1.45s software. Statistical analysis was 
performed using Microsoft Excel software. 
 
 
7.5. Senescence associated β-galactosidase staining 
Senescence associated β-galactosidase staining at pH 6.0 was performed as 
previously described (Debacq-Chainiaux et al., 2009). To avoid confluence-
induced SA-β-gal activity, staining was carried out on subconfluent fibroblast 
populations on the fifth experimental day. Cells on glass and nanopatterned 
cover slips were washed with PBS and fixed with 2% formaldehyde-0.2% 
glutaraldehyde (Naxo) in PBS for 5 min at room temperature. Followed by 
washing, the cells were transferred into freshly prepared staining buffer for 16 h 
at 37°C. After incubation the cover slips were washed with PBS and methanol 
(Naxo) and air-dried. For imaging we used an Olympus BX50 light microscope 
(Olympus Company Ltd.) and the Cell Imaging System Software (Olympus 
Company Ltd.). 
 
 
8. Fibroblast cultivation on thermally cross-linked  
glucose-containing electrospun gelatin meshes (Paper III) 
8.1. Designing fibrous glucose-containing gelatin meshes 
Gelatin type A from porcine skin (Sigma-Aldrich) and gelatin type B from 
bovine skin (Sigma-Aldrich) were used for electrospinning of fibrous scaffolds. 
Gelatins were mixed with D-(+)-glucose at different ratios (approximately 
0%, 5%, 10%, 15%, 20%, 25%, 30% of glucose in total weight of the glucose 
and gelatin powder mix; x%=mass of glucose/(mass of glucose + mass of 
gelatin). The mixtures were dissolved in 10 M aqueous acetic acid (Sigma-
Aldrich) solution at about 40°C by vigorous stirring to obtain solutions con-
taining 25% gelatin. A syringe containing gelatin solution was mounted on a 
New Era Pump Systems NE-511 pump operating at speeds between 6 and  
8 μl/min. High voltage between 17 and 18 kV was applied to metallic syringe 
needle using Heinzinger LNC 30,000 high voltage power supply. A grounded 
target was placed 14 cm away from the needle tip. Fibrous meshes were 
collected from the target after electrospinning and stored for further treatment. 
Gelatin scaffolds were cross-linked thermally by placing them in an oven for 
3 h. In order to avoid thermal degradation of gelatin while obtaining proper 
cross-linking (Birshtein and Tulchinskii, 1982) and to operate above melting 
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point and caramelization temperature of glucose, cross-linking was carried out 
at 170–175°C. Additionally, pieces of some scaffolds were removed from the 
oven after various times between 5 min and 3 h and analyzed to monitor the 
cross-linking process. 
 
 
8.2. Assessment of biological properties 
8.2.1. Glucose measurement 
Quantitative glucose oxydase and peroxidase kit (Spinreact) was used accor-
dingly to the manufacturer's protocol in order to detect possible leaching of 
glucose from the scaffolds. The forming hydrogen peroxide binds to chromo-
genic oxygen acceptor (phenol) and indicates the amount of glucose. Scaffolds 
were soaked in phenol red free medium DMEM (PAA Laboratories GmbH) for 
8 hours at 37°C. Incubated medium was removed for glucose measurements and 
followed by replacement with fresh medium for the next 8 hours. DMEM was 
removed before glucose detection. Spectrophotometer (Tecan) with Magellan 
(Tecan Group Ltd.) software was used at 505 nm wavelength to detect the 
intensity of a red quinoeimine dye, which is proportional to glucose con-
centration in the samples. 
 
 
8.2.2. Quantification of viable cells 
CellTiter-Glo® Luminescent Cell Viability Assay® (Promega) was used to 
quantify the number of viable cells grown on the scaffolds according to the 
manufacturer's protocol. Cell viability tests were performed 16 hours and 7 days 
after seeding. The readings were detected using Tecan Infinite M200Pro 
luminometer. 
 
8.2.3. Protein mass spectrometry (MS) 
Protein MS was performed by using LTQ Orbitrap XL (Thermo Fisher) mass 
spectrometer. MaxQuant 1.4.0.8 software was used for protein identification 
according to the manufacturer's protocol. Samples were incubated overnight at 
4oC and purified with StageTips (C18) after in-solution digestion with proteases 
lysC and trypsin in 8 M urea. Nano liquid chromatography-tandem MS analysis 
was performed using acetonitrile 8–40% gradient and 0.5% acetic acid. 
 
 
8.2.4. In vitro degradation of scaffolds 
The biological stability of the fibrous scaffolds was evaluated by exposing them 
to collagenase type II (2 units/ml; PAA Laboratories GmbH), collagenase type 
IV (160 units/ml; Gibco) and 0.25% trypsin-0.1% EDTA (Invitrogen) for 24 
hours. Degradation tests were performed at 37oC in a horizontal shaker 
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9. Scanning electron microscopy (SEM) (Papers I, III) 
9.1. SEM of cells grown on silica surfaces 
Primary fibroblasts with density 2700 cells/cm2 were seeded onto silica surfaces 
and onto flat borosilicate glass (control). SEM was performed on the third 
experimental day of cell culture. Samples were briefly washed with PBS and 
fixed in Karnovsky buffer for 30 min at room temperature. After washing in 
PBS, the cells were dehydrated through alcohol gradient starting at 50% ethanol 
up to 100% ethanol. Samples were subsequently transferred to 100% hexa-
methyldisilazane (AppliChem) (drying agent, alternative to critical point 
drying) for 3 min and air-dried at room temperature. The samples were sputter 
coated with a 5 nm layer of gold using a Polaron SC7640 High Resolution 
sputter coater. SEM micrographs were acquired with FEI SEM Helios Nanolab 
600, Focused Ion Beam, EDX (Oxford instruments) with an accelerating 
voltage of 5 kV and cross-sections of samples were previously cut using 
focused ion beam (FIB). 
 
 
9.2. SEM of fibrous gelatin meshes 
SEM of the fibrous gelatin scaffolds were carried out on plain meshes (without 
seeded cells) and on scaffolds previously seeded with fibroblast. 
Fibroblasts with density of 2700 cells/cm2 were seeded onto fibrous scaf-
folds previously attached to glass cover slips for easier handling. Scaffolds with 
fibroblasts were collected 24h and 7 days after seeding, washed in PBS and 
fixed with Karnovsky buffer for 30 min at room temperature. After washing 
again, the cells were dehydrated through alcohol gradient starting at 50 % 
ethanol up to 100% ethanol and dried using Leica EM CPD300 critical point 
drier. Samples were sputter coated with a 5 nm layer of gold. Several images of 
every scaffold were recorded and fibre diameters were measured from three 
representatives at 21,000 times magnification with and imaged by Tescan SEM 
Vega II. 
 
9.3. SEM of adult’s skin biopsy 
One adult’s whole skin sample was used for SEM imaging the physiological 
ECM sample of skin. The skin sample was fixed in freshly made Karnovsky 
buffer (with Na-cacodylate) for 4 hours. After fixation, the sample was washed 
three times in 0.2M Na-cacodylate (Sigma-Aldrich) buffer, each time for  
10 min. Postfixation was performed with 2% osmiumtetraoxide-0.2M Na-
cacodylate buffer for 1 hour. The sample was washed twice in 0.2M Na-
cacodylate buffer and followed by critical point drying procedure. The skin 
sample was imaged by Tescan SEM Vega II. 
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10. Statistical analysis (Papers I, II, VI) 
10.1. Analysis of RNA-Seq data 
Sequencing of cDNA libraries resulted in 24,842,284 to 44,324,428 paired 
reads per sample. For greater mapping quality, the initial 75 bp F3 and 35 bp F5 
reads were trimmed to 45 and 25 base pairs, respectively. All color-spaced reads 
were aligned to human reference genome (Ensembl, release 73) using TopHat 
v2.1.0 (Kim et al., 2013) that used Bowtie version 1.0.0 (Langmead et al., 
2009). RPKM values for gene expression levels were calculated with Cufflinks 
v2.0.2 (Roberts et al., 2011) and raw counts were retrieved with HTSeq version 
0.5.3p9 (http://www-huber.embl.de/users/anders/HTSeq/) using gene annota-
tions of protein coding genes downloaded from Ensembl (release 73). 
Differential expression was estimated on raw counts with edgeR (Robinson et 
al., 2010). All programs were used with their default parameters with TopHat 
set to not to find novel junctions. 
 
 
10.1.1. Modeling background regions 
To estimate the number of truly expressed genes we modeled intergenic regions 
using a methodology described in (Ramskold et al., 2009). Models of intergenic 
regions are expected to reflect the level of background expression (noise), 
which is taken as the baseline when estimating the number of expressed genes. 
For each gene, the length of the background region was equal to the gene's 
longest combined transcript (the sum of all transcribed nucleotides) and it 
extended upstream from position -1000 relative to the transcription start site. 
Only background regions that did not overlap with any expressed sequence tags 
(EST) were used in the analysis. A gene was considered as expressed only if the 
RPKM value in all samples of the corresponding cell type was above the cutoff 
(0.95). Conversely, the gene was labeled as not expressed if the RPKM value 
was below 0.95 in at least one of the samples. EST annotations were down-
loaded using UCSC Table Browser (http://genome.ucsc.edu/cgi-bin/hgTables) 
 
 
10.1.2. Differential expression analysis of gene expression 
Differential expression between melanocytes and samples from keratinocytes, 
fibroblasts and the whole skin was estimated using edgeR (Robinson et al., 
2010). A gene was considered as differentially expressed if the FDR-adjusted p-
value was below 0.05 and if the gene was expressed in at least one of the cell 
types. To identify a gene as expressed only in melanocytes and not in keratino-
cytes, fibroblasts (termed as “uniquely expressed in melanocytes”) it had to 
meet the following requirements: 1) RPKM > 0.95 in melanocytes (gene is 
labeled as expressed in melanocytes), 2) RPKM < 0.95 in keratinocytes, fibro-
blasts (gene is labeled as not expressed in keratinocytes, fibroblasts), 3) 
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differential expression FDR < 0.05 (gene is differentially expressed in melano-
cytes with respect to keratinocytes and fibroblasts). 
 
 
10.1.3. Pathway analysis of differentially expressed genes 
Gene ontology enrichment analysis of differentially expressed genes was per-
formed using g:GOSt (http://biit.cs.ut.ee/gprofiler/index.cgi) (Reimand et al., 
2011). Based on the p-values of g:GOSt analysis, GOsummaries package were 
used to generate word clouds of gene names (http://cran.r-project.org/web/ 
packages/GOsummaries/index.html). The word sizes in word clouds are defined 
by the p-values. Additionally, multidimensional scaling test for visualizing the 
level of similarity of individual samples in study groups was performed using 
edgeR. The results confirm the homogeneity and purity of cell populations. 
 
 
10.2. Statistical analysis for qRT-PCR analyses 
Relative gene expression levels were calculated using 2-∆CT method utilising 
the housekeeping gene HPRT-1 as an internal control (Livak and Schmittgen, 
2001). The data of all studied genes that followed normal distribution (using 
D’Agostino & Pearson omnibus normality test) were parametrically tested by 
unpaired t-test and the data not following normal distribution by Mann-Whitney 
t-test. 
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RESULTS 
1. Interleukin-10 family cytokines in the skin and skin cells 
(Paper II) 
Interleukin-10 family cytokines, which have been shown to mediate pro- and 
anti-inflammatory signals in several skin disorders (Ouyang et al., 2011) are 
also considered to be important players in regulating immune tolerance and, 
thereby, transplant rejection. 
Since the main goal of my research was to contribute to the discovery of 
novel materials for skin replacement therapies, we first focused on studying the 
IL-10 family of cytokines (Paper II). Among other processes, the cytokines 
regulate how cells respond to contacts with foreign materials. First, we studied 
the baseline gene expression profiles of juvenile keratinocytes, melanocytes and 
fibroblasts grown in standard tissue culture conditions. 
We saw that the mRNAs corresponding to selected IL-10 family cytokines 
(IL10, IL19, IL20, IL22, IL24, IL26, IL28B, IL29) and their receptors (IL10RA, 
IL10RB, IL20RA, IL20RB, IL22RA1, IL22RA2, IL28RA) were differential 
expressed between cultivated melanocytes, keratinocytes and fibroblasts. 
IL10 was not detectable in any of these cell types. In melanocytes and 
fibroblasts cultures, IL10RA was expressed at a very low level while in 
keratinocytes the expression level was below the detection limit (Figure 4a). In 
contrast, IL10RB was expressed at a high level in melanocytes, keratinocytes 
and fibroblasts. IL20 could be detected only in keratinocytes (Figure 4c). 
Interestingly, the IL20 receptors IL20RA and IL20RB had significantly higher 
expression in keratinocytes compared to fibroblasts and melanocytes, 
suggesting the existence of an autocrine positive feedback loop. The expression 
level of IL22RA1 was similar in keratinocytes and fibroblasts, whereas no 
expression could be detected in melanocytes (Figure 4f). At the same time, no 
expression of IL22RA2 as well as IL26 could be detected in any of the three 
cultures (data not shown). IL24 was the most prominent cytokine in melano-
cytes within the studied IL-10 family cytokines. However, IL24 was hardly 
detectable in keratinocytes and fibroblasts (Figure 4g). To mimic an in-
flammation-like state, we treated the cells with lipopolysaccharide (LPS), which 
is a strong pro-inflammatory agent. Notably, IL24 was the only studied gene 
induced by low concentration of LPS stimulation in cell culture, increasing up 
to 10 times in melanocytes (Figure 4g). IL28RA gene expression was signi-
ficantly higher in keratinocytes compared to melanocytes and no expression was 
detectable in fibroblasts (Figure 4h). 
Immunohistochemistry (IHC) in skin sections demonstrated that the expres-
sion of IL10RB protein (Figure 6a) and corresponding mRNA (Figure 5c) 
correlated well in juvenile skin. IL10RB protein could be detected in all skin 
layers (Figure 6a) and correspondingly, the IL10RB mRNA expression was 
similar in cultured melanocytes, keratinocytes and fibroblasts cells (Figure 4b).  
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Figure 4. mRNA expression of IL10RA, IL10RB, IL20, IL20RA, IL20RB, IL22RA1, 
IL24, IL28RA in cultivated melanocytes (Mc), keratinocytes (Kc), fibroblasts (Fb) and 
LPS stimulated melanocytes (Mc_LPS). Data is plotted as the mean ± SD of 15 
replicates. p-values are shown on graphs. Statistical methods used: d, g, h: Mann-
Whitney t-test, f: Unpaired t-test. 
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Due to excellent viability and high proliferation rate the cells extracted from 
juvenile skin are often used for tissue engineering purposes. At the same time, 
the tissue-engineered products containing juvenile cells are used to a large 
extent in adults. For this reason, the knowledge about the molecular differences 
between adult and juvenile skin cells is of utmost importance. 
IL10, IL10RA, IL10RB, IL20, IL20RA, IL20RB, IL22RA1, IL22RA2, IL26, 
IL28RA were all expressed in the juvenile skin. However, IL10, IL20 and IL26 
had extremely low and varying expression level (Figure 5). In the adult skin we 
detected the expression of IL10, IL10RA, IL10RB, IL20RA, IL20RB, IL22RA1, 
IL22RA2, IL28RA mRNAs. In contrast to the juvenile skin, IL20 and IL26 were 
not detectable in adult skin (Figure 5). IHC revealed no detectable IL26 staining 
in juvenile and adult skin (Figure 6c, i). Furthermore, gene expression of 
IL28RA was present in keratinocytes culture (Figure 4h), but the respective IHC 
analysis did not reveal any staining in the epidermis (Figure 6d). In the adult 
skin, IHC analysis revealed IL28RA positive staining in juvenile epidermis 
(Figure 6j). 
IL10RB was expressed at detectable levels in both adult and juvenile skin, 
however, its expression was considerably higher in the adult skin (Figure 5c). 
This was also confirmed by IHC, which revealed clearly stronger immunere-
activity in the adult skin (Figure 6a, g). IL24 RNA was not detectable in 
juvenile and adult whole skin (data not shown). Similarly, the gene expression 
of IL19, IL22, IL28B and IL29 was not detectable neither in whole skin samples 
nor in the cultured cells (data not shown). Further, we could not detect the 
presence of IL22RA2, IL26 and IL29 protein in skin sections (Figure 6b, c, e) 
and the corresponding mRNAs were not detected in any of the cell cultures 
(data not shown). 
A summary of the IL-10 family expression in adult and juvenile whole skin 
and in cultured juvenile skin cells is presented in Table 2. 
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Table 2. Overview of the expression levels of the IL-10 family genes in adult and 
juvenile whole skin, as well as in juvenile skin cells. +: mean 2-∆CT 0.001–0.009; ++: 
mean 2-∆CT 0.01– 0.09; +++: mean 2-∆CT ≥ 0.1–0.9; ++++: mean 2-∆CT ≥ 1. 
 
Genes Children Adults Keratinocytes Melanocytes Fibroblasts 
IL10 ++ ++ – – – 
IL10RA +++ +++ – + + 
IL10RB +++ ++++ +++ +++ +++ 
IL19 – – – – – 
IL20 ++ – ++ – – 
IL20RA +++ +++ +++ – ++ 
IL20RB ++++ ++++ ++++ + ++ 
IL22 – – – – – 
IL22RA1 ++++ +++ +++ – ++ 
IL22RA2 +++ ++ – – – 
IL24 – – ++ +++ + 
IL26 ++ – – – – 
IL28RA +++ ++ ++ ++ – 
IL28B – – – – – 
IL29 – – – – – 
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Figure 5. mRNA expression of IL10, IL10RA, IL10RB, IL20, IL20RA, IL20RB, 
IL22RA1, IL22RA2, IL26 and IL28RA in adult and juvenile whole skin samples. Data is 
plotted as the mean of 15 replicates ± SD. p-values are shown on graphs. Statistical 
methods used: c, g h and j: unpaired t-test. e: Mann-Whitney t-test. 
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Figure 6. Immunohistochemistry (IHC) staining of juvenile and adult whole skin 
sample. Skin specimens (n = 5, both in juvenile (A–F) and adult (G–L) group) were 
stained with thionine blue (blue background staining) and the antibodies for IL10RB, 
IL22RA2, IL26, IL28RA, IL29 (brown color indicates positive antibody reaction); 
IL10RB (A, G) antibody staining was present in all layers of adult and juvenile skin, but 
a significantly weaker antibody reaction in juvenile samples was observable. We 
detected IL28RA-positive antibody reaction (D, J) in adult epidermis, but no significant 
staining in juvenile skin. No observable antibody staining of IL22RA2, IL26 and IL29 was 
detected. Negative control for antibody staining is shown in (F, L). Scale bars: 200 mm. 
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Figure 6 (continued) 
 
 
2. Whole transcriptome sequencing (Paper IV) 
In order to describe more systematically the global differences in the gene 
expression profiles of the main skin constituents and to expand our knowledge 
about the intracellular pathways active in these cells when grown in standard 
tissue culture conditions, we performed a comparative whole transcriptome 
analysis of cultivated keratinocytes, fibroblasts and melanocytes. In Paper IV 
we outlined the specific features of melanocytes compared to keratinocytes, 
200µm200µm
200µm200µm
200µm200µm
D J
E K
F L
IL
28
RA
IL
29
ne
g.
 co
nt
r.
42 
fibroblasts and the whole skin. In parallel, we investigated the differences 
between keratinocytes and fibroblasts and compared their transcriptome to that 
of the whole skin. 
 
 
2.1. Overall differences between cultivated melanocytes, 
keratinocytes, fibroblasts and whole skin tissue 
As expected, the total number of expressed genes was the highest in whole skin 
samples (10,871 genes), since other cell types besides keratinocytes, melano-
cytes and fibroblasts (epithelial cells, Merkel cells, Langerhans cells etc.) are 
present in whole skin biopsy (Table 3). Interestingly, the total number of ex-
pressed genes was the lowest in keratinocytes (Table 3). Thereat, 7,766 genes 
were commonly expressed in all study groups (whole skin and keratinocytes, 
melanocytes and fibroblasts). The list of the detected genes and their RPKM 
values can be found in http://journals.plos.org/plosone/article/asset?unique& 
id=info:doi/10.1371/journal.pone.0115717.s002. Similarly, the number of genes 
considered as uniquely expressed was the largest in the whole skin sample (290 
genes, Table 3). 
 
 
Table 3. The number of detected and uniquely expressed genes. 
 
 Total number of expressed 
genes
Uniquely expressed  
genes
Skin 10871 290 
Keratinocytes 8937 138 
Melanocytes 9903 122 
Fibroblasts 10420 277 
 
 
When comparing specific cell populations, fibroblasts had a higher number of 
uniquely expressed genes compared to melanocytes and keratinocytes (277, 122, 
138 uniquely expressed genes, respectively) (Table 3). It is likely that the true 
number of uniquely expressed genes is higher as we applied a relatively strict cut-
off criterion (RPKM > 0.95) when calling gene expression as present or absent. 
Based on the differential gene expression analysis, we identified signifi-
cantly fewer similarities between melanocytes and whole skin gene expression 
patterns than when comparing keratinocytes or fibroblasts to the whole skin. In 
melanocytes, 6,231 genes were differentially expressed compared to the whole 
skin. Of those, 3,680 were upregulated in melanocytes and 2,551 downregulated 
in melanocytes (Figure 7). The number of differentially expressed genes when 
compared to whole skin was 4,480 in keratinocytes and 4,454 in fibroblasts 
(Figure 7). This finding can be explained by the relatively small proportion of 
melanocytes of the total skin cell number. The entire list of differentially 
expressed genes can be found in http://journals.plos.org/plosone/article/ 
asset?unique&id=info:doi/10.1371/journal.pone.0115717.s003. 
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Additionally, there are more upregulated genes in melanocytes and fibro-
blasts than in keratinocytes when these cells were compared to each other – 
2,239 genes were upregulated in fibroblasts, but only 1,377 genes were up-
regulated in keratinocytes and 2,498 genes in melanocytes in comparison with 
keratinocytes where only 1,855 genes were upregulated (Figure 7). At the same 
time the number of differentially upregulated genes did not differ significantly 
when melanocytes and fibroblasts were compared: 1,230 versus 1,511 up-
regulated genes, respectively (Figure 7). 
 
 
 
Figure 7. The number of differentially expressed genes in each study group – melano-
cyte (MC), keratinocyte (KC), fibroblast (FB) and whole skin (Skin). For example, 
comparing gene expression in keratinocytes and whole skin samples – 2,492 genes were 
upregulated in keratinocytes (grey triangle) compared to whole skin samples (white 
triangle), where only 1,988 genes were upregulated (Figure 7). 
 
 
2.2. Pathway analysis of the skin cells and whole skin 
Pathway analysis brought forth the most characteristic differences between 
melanocytes, keratinocytes, fibroblasts and whole skin (Figure 8). In Paper IV, 
we focused on the pathway analysis of melanocytes. List of pathways (based on 
differentially expressed genes), prominent in MC compared to KC, FB and 
whole skin can be accessed via http://journals.plos.org/plosone/article/asset? 
unique&id=info:doi/10.1371/journal.pone.0115717.s004. The analysis revealed 
that cultured melanocytes could be described as an active and intensively 
dividing cell population (Figure 8). In addition to the genes involved in mela-
nosome organization and pigment synthesis, we identified a number of genes 
that were characteristic for ongoing regenerative process and could be related to 
cell division: genes regulating mitotic activity and cell cycle; DNA replication 
and chromatin assembly; assembly and metabolism of different cellular com-
ponents (cytoskeleton, structural macromolecules), formation of lysosome and 
Golgi complex (Figure 8). Consequently, gene expression profile corresponding 
to enhanced metabolic activity could be also observed (Figure 8). 
Additionally, we saw that in melanocytes and fibroblasts the upregulated 
genes represented a more heterogeneous list of pathways than in keratinocytes 
where the upregulated genes were mostly related to the differentiation of kerati-
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nocytes, development of epidermis and formation of intercellular connections 
(tight junction) in the epidermis (Figure 8). In the case of fibroblasts the up-
regulated genes were mostly part of the pathways, which regulate the organi-
zation of the extracellular matrix and the development of anatomical structures 
and are related to cell motility and migration processes. 
 
  
 
A  melanocytes vs skin
B  melanocytes vs keratinocytes
C  melanocytes vs fibroblasts
 
  
 
 
Figure 8. Comparative pathway analysis of melanocytes, keratinocytes, fibroblasts and 
whole skin. On plots A, B and C, red squares indicate pathways, which were promi-
nently expressed in melanocytes (MC) and blue squares mark pathways, which were 
downregulated in melanocytes and concomitantly upregulated in the whole skin (A), 
keratinocytes (KC) (B) and fibroblasts (FB) (C), respectively. On plots D and E red 
squares indicates pathways, which were prominently expressed in keratinocytes and 
blue squares, which were upregulated in fibroblast and whole skin, respectively. On plot 
F red square marks upregulated pathways in fibroblasts compared to whole skin, the 
upregulated pathways of which are marked by blue color. The word sizes in word 
clouds were defined by their p-values. 
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Figure 8 (continued)       
 
 
  
D  keratinocytes vs fibroblasts
F  fibroblasts vs skin
E  keratinocytes vs skin
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2.3. Characterization of gene expression pattern of juvenile 
keratinocytes, melanocytes and fibroblasts 
Comparing melanocytes, keratinocytes and fibroblasts, we found several gene 
groups, which distinguish cultured melanocytes from other skin cells. 
The most prominent group of genes differentially expressed in melanocytes 
compared to fibroblasts was that of encoding various histone proteins 
(HIST1H1A, HIST1H1B, HIST1H2AA, HIST1H2AE, HIST1H2AG, HIST1H2AI, 
HIST1H2BB, HIST1H2BH, 
HIST1H2BI, HIST1H2BN, HIST1H3D, HIST1H3F, HIST1H3H, HIST1H3J, 
HIST1H4D, HIST1H4I, HIST1H4L, HIST2H3D, HIST3H2A, HIST3H2BB and 
HIST4H4). Another group of genes differentially expressed between melano-
cytes and fibroblasts was related to cell division cycle (CDC20, CDC25A, 
CDC25C, CDC6, CDCA2, CDCA5 and CDCA8). Additionally, a set of kinesin 
family genes (KIF13B, KIF20B, KIF21A, KIF22, KIF24, KIF2C, KIFC1) was 
differentially expressed in melanocytes compared to fibroblasts. Also, 
significantly higher expression of calcium-binding proteins S100A1, S100A14, 
S100A8, S100A9 and S100B genes was observable in melanocytes compared to 
fibroblasts. 
When compared to keratinocytes, melanocytes expressed a set of major 
histocompatibility complex protein genes such as HLA-B, HLA-DMA, HLA-
DPB1, HLA-DRA and HLA-F. In addition, interferon-induced protein genes 
IFI27, IFI35, IFI44, IFI44L, IFI6, IFIT1, IFIT2, IFIT3, IFITM1, IFITM2 and 
IFITM3, which are related to viral and bacterial infection defense mechanism 
(Itsui et al., 2006), were highly expressed in melanocytes when compared to 
keratinocytes. So far the keratinocytes have been shown to be the key players in 
modulating the immunological status of normal and diseased skin by being the 
first sensors of harmful agents, secreting inhibitory and stimulating cytokines, 
and activating other immune competent cells (e.g. Langerhans cells) (Burgdorf 
et al., 2009). Our data suggest that the role of melanocytes in cutaneous immune 
system regulation might be more extensive than anticipated so far. 
Importantly, we could identify a set of melanocytes-specific genes pre-
viously not described by other researchers (Table 4). In many cases the 
functions of these genes are poorly characterized and further experiments are 
needed to identify their precise role in melanocytes. A number of genes that 
were unique for melanocytes (CA8, CHRNA6, CTTNBP2, EPHA5, FAXC, 
KCNN2, SCG2, SLITRK2) refer to melanocytes’ origin from the neural crest 
(Kos et al., 2001, Chakrabarty et al., 2012, Jiao et al., 2005, Chen and Hsueh, 
2012, Akaneya et al., 2010, Szatanik et al., 2008, Hotta et al., 2009, Yim et al., 
2013, Hill et al., 1995) (Table 4). 
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As already indicated by the pathway analysis, fibroblasts are the crucial players 
in extracellular matrix synthesis and degradation processes. In Table 5 we have 
pointed out the expression of genes coding extracellular matrix proteins in 
fibroblasts. In our study, a gene was considered as expressed only if the RPKM 
value in all samples of the corresponding cell type was above the cutoff (0.95). 
We could detect COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL4A5, 
COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL7A1, COL8A1, 
COL8A2, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, 
COL18A1, COL21A1 and COL27A1 in cultivated fibroblasts. In addition to 
collagen, we also detected genes, which encode laminin chains LAMA1, 
LAMA2, LAMA3, LAMA4, LAMB1, LAMB2, LAMB3, LAMC1, LAMC2 in 
fibroblasts (Table 5). However, besides fibroblasts, the keratinocytes and 
melanocytes also synthesize the components of the ECM. For example, laminin 
alpha 1 gene LAMA1 was highly expressed in melanocytes when compared to 
keratinocytes and fibroblasts suggesting that melanocytes might have a role in 
ECM formation and remodeling and might refer to a higher potential of 
melanocytes to transform into tumorous cells since LAMA1 is expressed 
predominantly in embryonic tissues (Ekblom et al., 2003). The list of the 
RPKM values can be accessed via http://journals.plos.org/plosone/article/ 
asset?unique&id=info:doi/ 10.1371/journal.pone.0115717.s002. 
 
 
3. Cells on nanopatterned surfaces (Paper I) 
During the cultivation of different skin cell types we identified fibroblasts as the 
most accessible and easy-to-grow cell population, which yields a homogeneous 
cell culture. For this reason juvenile skin fibroblasts were used as a model 
system for testing the cell-compatibility of novel biofunctional surfaces. 
In Paper I we compared the growth properties of normal human primary 
fibroblasts on silica surfaces with round nano- and micropatterns of different 
sizes. As a reference we used smooth sol-gel prepared silica surface and 
untreated borosilicate glass inserts commonly used for cell culturing. Our goal 
was to evaluate the biocompatibility of these materials and to study how the 
micro- and nanopatterns with different configurations on substrate influence the 
spreading and growth of cultivated primary cells. 
 
 
3.1. Surface design 
Substrate patterns of different size nano- and micro-domes were prepared using 
different solvents (propanol (S1), ethanol (S2), methanol (S3) and methanol 
(S4)), in TEOS-based precursors. The surface of smooth samples, prepared 
using solvent – hexane, showed no noticeable roughness in relevant lateral scale 
in SEM analysis. The characteristics of different silica surfaces can be found in 
Table 6. The hydrophilic properties of surfaces were characterized by water 
droplet contact angle method. Relatively small contact angle of S3 is due to the 
rather flat dome structure (Figure 9C). 
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Figure 9. Scanning electron microscopy analysis of silica domes S1 (A), (B), S3 (C) 
and S4 (D). The inset on the picture “A” shows a magnification of the S1 surface. 
 
 
Table 6. The characteristics of different silica surfaces. 
 
Mean diameter 
of the dome 
Mean height of the 
dome (nm) 
Number of domes 
per 10 000 μm2 
Surface-dome 
contact angle (°) 
S1 200 nm 90 51,000 48 
S2 500 nm 210 24,000 54 
S3 1 μm 200 4,300 15 
S4 10 μm 920 18 34 
 
 
 
3.2. Cell morphology 
Primary fibroblasts adhered, grew and proliferated on all studied surfaces, 
indicating that the composition of the used material is compatible with cells. 
However, the cells grown on surfaces with different topography displayed 
changes in morphology showing a role for surface roughness in regulating cell 
growth (Figure 10A–C, G–I).) On a flat surface, fibroblasts usually maintain 
their “normal” spindle-shaped morphology (Figure 10n). However, on S3 and 
S4, a portion of cells were either spread out showing drastically increased cell 
size or, alternatively, became stretched out and obtained a narrow cytoplasm 
and an oval nucleus (Figure 10M, O). It has been shown that such cells do not 
proliferate and represent most probably either senescent or stressed cells, 
respectively (Chen et al., 2000). 
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Figure 10. Confocal fluorescence microscopy images of normal human dermal 
fibroblasts cultured on silica domes S1 (A), S2 (B), S3 (C), S4 (G), smooth surface (H), 
borosilicate glass (I). SEM micrographs of cultured fibroblasts on silica domes S1 (D), 
S2 (E), S3 (F), S4 (J), smooth silica surface (K) and borosilicate glass (L). Confocal 
fluorescence images of fibroblasts with different morphology (M–O): M – enlarged cell; 
N – spindle-shaped normal cells; O – narrowed cells. The cytoskeleton of the cells is 
labeled with anti-gamma actin (green) and nuclei are labeled with DAPI (blue). Red 
arrows mark the domes. Scale bar: 50 µm. 
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3.3. The induction of cell senescence on nanopatterned surfaces 
Senescence-associated beta-galactosidase (SA-b-gal) activity allows to detect 
cells undergoing a limited number of doublings in culture before irreversibly 
arresting proliferation (becoming senescent) (Debacq-Chainiaux et al., 2009). 
We used this method to study whether different nanopatterned surfaces could 
inhibit the proliferation of cells via induction of senescence. We could confirm 
the presence SA-b-gal staining in significantly enlarged cells, which occasional-
ly had a surface up to 10 times larger than of normal cells (data not shown). 
The number of senescent cells grown on S1 and S2 substrates was similar to 
the number of such cells on flat surfaces (Figure 11A). In contrast, cells grown 
on S3 and S4 substrates displayed an increased proportion of enlarged cells and 
decreased proportion of cells with narrow cytoplasm (Figure 11A). Further-
more, the amount of fibroblasts positive for SA-b-gal staining was increased 
when cells were grown on S3 and S4, suggesting that increasing the dome size 
of the surface increases the induction of cell senescence (Figure 11B). 
 
 
3.4. The regulation of cell proliferativity by nanopatterned surfaces 
Ki67 antibody staining recognizes a proliferation-specific nuclear antigen 
expressed by proliferating cells in late G1, S, G2 and M phases, but not in 
resting cells (Kill, 1996, Gerdes et al., 1984). It has been used widely for the 
estimation of the growth fraction of normal cells in culture. Previous studies 
have shown that the level of Ki67-positive cells decreased with time of culture 
and number of cell passages (Knuchel et al., 1990). To avoid this tendency, 
cells from the third and fourth passage were used in our experiment. 
In concordance with the presence of the increased number of senescent cells 
on S3 and S4 surfaces, we found that the number of Ki67-positive nuclei was 
slightly decreased in the cells grown on S3 and S4 (Figure 11C). 
 
 
Figure 11. Regulation of cell senescence and cell proliferativity by nanopatterned 
surfaces. Graphs describe the percentage of cells with atypical morphology (A), ratio of 
SA-b-gal positive per 105 normal cells (B) and mean percentage of Ki-67-positive cells 
per total number of cells (C). Error bars: ± SD. 
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3.5. Scanning electron microscopy (SEM) and focused ion beam 
(FIB) imaging of the cells grown on sol–gel prepared silica surface 
To obtain more detailed insight into the possible reasons behind the morphology 
changes described above, we performed SEM imaging of the cells grown on 
different surfaces (Figure 10D–F, J–L). One striking difference between cells 
grown on S3 and S4 is the lack of filopodia of cells grown on S3 (Figure 10F). 
Instead, the cells grown on S4 stretch out long filopodia (Figure 10J). 
To investigate the attachment of cells to the nanopatterned surface, we 
imaged the vertical cuts of the cell-substrate interface by FIB. The cells grown 
on S1 displayed tight attachment to the substrate with no gaps present between 
the cell membrane and the material (Figure 12A). Cells grown on S2 attached 
incompletely to the substrate with occasional gaps present (Figure 12B). These 
changes were more pronounced in the cells grown on S3, where cells were 
attached only to the domes and contact with the substrate in between the domes 
was practically absent (Figure 12C). The cells grown on S4 attached both to the 
domes and to the space between them (Figure 12D). 
 
 
 
 
Figure 12. Cross-sectional imaging. SEM micrographs of cross sections performed with 
focused ion beam (FIB) of fibroblasts on silica domes S1 (A), S2 (B), S3 (C) and S4 (D) 
indicate cell-surface integration between different sizes of domes. 
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4. Design of thermally cross-linked glucose-containing 
electrospun gelatin meshes (Paper III) 
In Paper I we found that nanopatterned silica material does supports the growth 
of primary skin fibroblasts. However, in order to create more tissue-specific and 
elastic materials for skin engineering, we continued by studying in vitro synthe-
sized biopolymer compositions. In Paper III we investigated the use of ther-
mally cross-linked glucose-containing electrospun gelatin meshes as possible 
cell substrates for ex vivo growth. 
Electrospinning the gelatin solutions with different glucose concentrations in 
the presence of acetic acid produced a smooth and uniformly structured fibrous 
scaffold as confirmed by SEM (Figure 13). Scaffolds with glucose concent-
ration up to 50% were electrospun successfully. However, at glucose 
concentration 30% and higher, the scaffold became extremely fragile and was 
therefore excluded from the study. 
Samples with different glucose concentrations in spinning solution differed 
mainly by fibre diameter. Average fibre diameters varied between 250 and 600 
nm. The fibre diameter was the smallest at 5% glucose concentration and 
increased with higher glucose concentrations in the electrospinning solution. 
Additionally, the samples with lower glucose concentration tend to have more 
loosely packed fibres (Figure 13). Thermal cross-linking did not alter detectably 
the microstructure of collagen scaffolds as visualized by SEM (Figure 13). 
We used FTIR spectroscopy to analyse the effect of glucose on structural 
changes during thermal cross-linking, to determine the optimal time of exposure 
to cross-linking temperature and to evaluate the extent of cross-linking. We 
used both type A and type B gelatin in our study. Since there were small diffe-
rences between the FTIR spectra of type A and type B gelatin scaffolds, a mass 
spectrometry analysis was carried out to study the differences in the protein 
content of type A and type B gelatins. We found that the content of proteins and 
their fragments in gelatin type A and type B powder differed significantly, 
being much pronounced in the case of type A gelatin (Table 7). 
 
57 
 
 
Figure 13. SEM images of gelatin scaffolds with different glucose content before (left) 
and after (right) thermal cross-linking: (a) 0%, (b) 5%, (c) 10%, (d) 15%, (e) 20%, (f) 
25%, (g) 30% glucose. Magnification 21,000 times. 
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Table 7. Protein mass spectrometry results. Protein profiles of gelatin type A and type 
B powders. Peak intensity corresponds to the relative abundance ratio of proteins. 
 
Gelatin, type A Intensity Gelatin, type B Intensity 
Protein name  Protein name  
collagen, type I, Alpha 2 7.02E+09 collagen, type I, alpha 1 1.95E+09 
collagen, type I, Alpha 1 2.98E+09 collagen, type I, alpha 2 1.35E+09 
fragments of collagen, type I, 
alpha 1 and alpha 2 1.23E+09 collagen, type III, alpha 1 1.33E+08 
collagen, type III, alpha 1 7.14E+08 decorin 2.69E+06 
collagen, type V, alpha 2 4.93E+08 
myosin, heavy chain 7, cardiac 
muscle, beta 1.61E+06 
albumin 1.02E+08 albumin 1.57E+06 
decorin 4.66E+07   
collagen, type V, alpha 1 4.05E+07   
lumican 3.27E+07   
orosomucoid 3.17E+07   
transferrin 2.11E+07   
osteoglycin 1.77E+07   
transthyretin 1.34E+07   
serpin peptidase inhibitor, clade 
A, member 3-3 1.12E+07  
 
uncharacterized protein 7.41E+06   
uncharacterized protein 4.24E+06   
collagen, type V, alpha 3 2.44E+06   
fragments of serpin peptidase 
inhibitor, clade A, member 3-3 9.42E+05  
 
chitinase, acidic 8.91E+05   
serpin peptidase inhibitor, clade 
A, member 3-2 3.17E+05  
 
 
 
4.1. Glucose measurements 
Next we seeded previously isolated juvenile fibroblasts onto the fibrous gelatin 
scaffolds prepared using different glucose concentrations. When conducting 
preliminary experiments, we noticed an increase in glucose concentration in the 
cell culture media after incubating the scaffolds in it. Since the changes in 
glucose concentration of the growth media could potentially influence the 
growth characteristics of the cells, additional experiments were carried out to 
find the reasons for this phenomenon. The scaffolds were incubated in DMEM 
and glucose concentration in the culture medium was measured. We found that 
after such incubation the glucose concentration in the growth media increased 
from 7% to 29% (Figure 14). DMEM contains normally 450 mg/dl (4.5%) 
glucose. The change in glucose levels for type B gelatin scaffolds was some-
what larger than for type A gelatin scaffolds (22.1% and 15.3% respectively). A 
probable explanation is that the degree of swelling is different for type A and 
type B gelatin. When the culture medium was replaced, the glucose level in the 
fresh medium did not increase. The amount of excess glucose in the medium 
did not correlate with glucose concentration present in gelatin blends. Further-
more, the glucose levels were also increased when gelatin scaffolds without 
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glucose addition were incubated in the media. We concluded that this effect can 
be attributed to water absorption during swelling of the scaffolds. Hence the 
swelling of scaffolds made from different types of gelatin or scaffolds with 
various cross-linking rate differs, the extent of increase of the glucose con-
centration in cell culture media were dissimilar. To avoid the changes in the 
media constitution, all the experiments were performed with matrices pre-
incubated in the growth medium. 
 
 
 
Figure 14. Changes in glucose concentration during swelling of electrospun matrices. 
Data is plotted as the mean of 3 replicates ± SD (error bars). 
 
 
4.2. Biological degradation 
Since one of the critical properties of the matrices used for tissue engineering is 
their biodegradability, we tested the efficacy of a selection of ECM-degrading 
enzymes in degrading the electrospun collagen scaffolds. 
The biological stability test of cross-linked gelatin scaffolds using digestion 
with collagenases (type II, IV) and trypsin showed that scaffolds with higher 
glucose content (25% and 30%) were resistant to digestion with all three types 
of enzymes, as scaffolds maintained their pre-treatment shape. Scaffolds 
containing 20% glucose were partially degraded. Matrices containing 15% and 
less glucose were totally dissolved in collagenase and trypsin solution and no 
undigested scaffold fragments could be observed under optical microscope. 
 
 
4.3. Cell proliferation 
Next, the viability and proliferation of the fibroblasts seeded onto the electro-
spun collagen scaffolds were studied using a luminometer-based cell viability 
assay. After 16 h of culturing, the number of cells attached to the scaffolds was 
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largely the same for all glucose concentrations. Seven days after seeding, the 
cells had started to proliferate and the number of fibroblasts increased re-
markably. Notably, at higher glucose concentrations (25% and 30%) the number 
of viable cells was significantly lower (Figure 15). However, the differences 
between the total number of cells grown on type A and type B gelatin scaffolds 
containing the same amount of glucose were marginal. The number of cells 
started to decrease at 10% (type B gelatin) and at 25% (type A gelatin) glucose 
concentrations (Figure 15). 
 
  
Figure 15. Dependence of ATP levels on glucose concentration 16 h and 7 days after 
seeding. ATP level is proportional to the number of cells grown on type A and Type B 
gelatin scaffold. Data is plotted as the mean of 3 replicates ± SD (error bars). 
 
 
4.4. Cell morphology 
SEM images confirmed the results of the proliferation tests. Cells grown on 
surfaces with glucose content of 25% and 30% tended to have a polygonal 
shape, lacked filopodia (Figure 16C) and appeared to have a flat morphology 
similar to the cells grown on 2D surface like plastic or glass (Figure 16D). On 
these scaffolds we saw a number of cells with a morphology characteristic of 
stressed cells – enlarged or serrate cell body, decreased number of attachment 
sites to the scaffolds, and partial detachment from the scaffold. That fits well 
with the results of the proliferation test, where we saw the decreased proli-
feration at glucose 20% and higher. 
The morphology of the fibroblasts grown on the scaffolds with glucose 
content 5–20% did not differ significantly, but displayed certain directional 
orientation, especially in regions where parallel ordering of fibres was evident 
(Figure 16B). And cells grown on the substrates with more loosely packed and 
disorganized fibres, were more stellate, formed more dendrites to connect to the 
surrounding scaffold and even localized below the fibers (Figure 16A). How-
ever the cross-sectional imaging of the scaffolds, using confocal microscopy, 
did not reveal any invasion of the fibroblast into the deeper layers of the 
scaffolds (data not shown). 
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Figure 16. Morphology of fibroblasts grown on scaffolds with different porosity, fibre 
density, orientation and diameter (2,500 times magnification). A) 5% glucose, B) 10% 
glucose, C) 30% glucose, D) glass. 
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DISCUSSION 
1. IL-10 family cytokines 
The immune status of the skin plays an important role in determining the 
susceptibility towards a number of illnesses, but also determines the course of 
wound healing. Therefore the cells and immunomodulating factors produced by 
the cells are actively involved in regenerative processes. IL-10 family cytokines 
have been shown to be important players both in anti- and proinflammatory 
processes. As an unresolved chronic inflammation in a wound finally leads to 
scar formation, the resolution of the early inflammatory cascade might be 
crucial for successful regeneration process (Atala et al., 2010). 
The aim of our study presented in Paper II was to localize cell populations 
with the expression of IL-10 family of cytokines in juvenile skin and to deter-
mine possible age-related differences in the expression of these genes. We 
found that the majority of the genes of IL-10 family and their receptors were 
detectable in juvenile skin (IL10, IL10RA, IL10RB, IL20, IL20RA, IL20RB, 
IL22RA1, IL22RA2, IL26, IL28RA). On the other hand, 50% of the genes 
expressed in juvenile skin were downregulated (IL22RA1, IL22RA2, IL28RA) or 
absent (IL20, IL26) in adults (Table 2). For several genes, for example IL10RB, 
we observed a significantly weaker or missing antibody reaction in juvenile 
samples when compared to adults (Fig 3a). In addition to IL10RA, IL10RB has 
been shown to be required for IL10-induced signal transduction and therefore 
may regulate susceptibility to various pathologies. For example, the mutations 
in IL10R genes cause severe and early childhood onset of the inflammatory 
bowel disease (Glocker et al., 2009). 
We also found that interleukin receptors are more prominently expressed in 
the skin than the interleukins themselves (Figure 5). This indicates that the skin 
cells are to a greater degree targets for circulating cytokines than a source of 
these. There were also differences in the expression of cytokine receptor sub-
units. Interestingly, the expression level of the receptor genes correlated with 
the overall prevalence and selectivity of respective subunits. For example 
IL10RA is unique to IL10R whereas IL10RB is shared by several other 
cytokines, including IL22, IL26, and IL28A IL28RB and IL29 (Table 1). 
Concurrently, there was a group of genes of the IL-10 family (IL19, IL22, 
IL28B, IL29), which have been shown to play a role in different skin disorders, 
such as psoriasis and infections (Gallagher, 2010, Sahoo and Im, 2012, Wolk et 
al., 2010). In healthy adult and juvenile skin their expression was undetectable 
(Table 2). It suggests that these cytokines are significantly expressed only in 
pathological conditions. For example IL28B and IL29, the newly discovered 
interferon-like cytokines in the IL-10 family, have been shown to exert their 
anti-viral, anti-proliferative, anti-tumor activity via the IL28RA and IL10RB 
receptor complex (Sheppard et al., 2003, Li et al., 2009). IL28 and IL29 can act 
synergistically with IL20 (Wolk et al., 2010), which is one of the most attractive 
potential target cytokines for psoriasis treatment (Stenderup et al., 2007). In 
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agreement with previous studies (Wei et al., 2005), we found IL20 to be absent 
in healthy adult skin (Figure 5d). The reason for the IL20 expression level 
fluctuation in juvenile whole skin (Figure 5d) and keratinocytes (Figure 4c) 
might be the higher proliferation activity of cells extracted from juvenile skin. 
In order to localize the expression of studied cytokines in the skin we 
analyzed the gene expression patterns of the three main cell types found in 
juvenile skin – the melanocytes, keratinocytes and fibroblasts. We found that 
mRNAs, which were undetectable in whole skin samples of both children and 
adults (IL19, IL22, IL28B and IL29), were also undetectable in cultured cells 
(data not shown). In this regard IL24 was exceptional as it was highly expressed 
in melanocytes (Figure 4g), but undetectable in juvenile and adult whole skin. 
Compared to fibroblasts and keratinocytes, the number of melanocytes in the 
skin is very small and, therefore, melanocyte-specific mRNAs are hardly 
detectable in whole skin samples. IL24 has been shown to induce growth arrest 
and apoptosis in melanoma cells (Sarkar et al., 2002) and is also considered to 
be an important mediator for chronic inflammatory conditions, e.g. psoriasis 
(He and Liang, 2010). We treated the cells with lipopolysaccharides (LPS), 
which are the major components of the outer membrane of gram-negative 
bacteria (Karima et al., 1999). LPS preparation is a strong pro-inflammatory 
compound, which promotes the secretion of pro-inflammatory cytokines such as 
IL1β, tumor necrosis factor alpha and IL10 from cells (Thakur et al., 2006, Ho 
and Ivashkiv, 2010). Interestingly, only the expression of IL24 was increased 
significantly in response to LPS stimulation and that occurred only in juvenile 
melanocyte culture (Figure 4g). This finding shows that melanocytes can react 
to the inflammatory signals and are able to produce cytokines, which suggests 
that they play a role in the regulation of immune defense mechanisms in skin. 
The unresponsiveness of the rest of interleukins to LPS stimulation could be 
explained by the fact that neonatal cells tend to have notably lower cytokine 
production in response to LPS compared to adults (La Pine et al., 2003, Joyner 
et al., 2000). We also have to take into account that LPS could activate the 
secretion of the cytokines directly, and not necessarily having any influence on 
gene expression. 
In conclusion, for the first time, we showed the difference of IL-10 family 
and its receptors between juvenile and adult skin. Additionally, our analysis of 
the expression of IL-10 family members in cultured skin cells revealed a cell 
type-specific cytokine production pattern, which helps to explain the roles of 
different cells in inflammation, regeneration and tissue rejection. 
 
 
2. Cell type-specific differences  
in the skin transcriptome 
To analyze in detail the differences between the three main cell types in skin – 
melanocytes, keratinocytes and fibroblasts – we determined the differences in 
their global gene expression profiles. Earlier, numerous gene expression 
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analyses of different skin cell populations have been performed using material 
isolated from normal and pathological samples (Lee et al., 2013, Lan et al., 
2011, Liu et al., 2009, Roberts et al., 2006, Hoek et al., 2004). Various mRNA 
quantification methods have been used, ranging from quantitative real time 
polymerase chain reaction and in situ hybridization to high throughput methods 
such as serial analysis of gene expression and microarrays. However, to our 
knowledge, the complete transcriptome analysis of the three skin cell types has 
not been performed before. To achieve this goal we performed high-throughput 
RNA sequencing of rRNA-depleted samples, which allowed us to detect nearly 
all coding and non-coding RNA species in a given sample. In our analysis we 
concentrated on melanocytes, which are highly outnumbered by keratinocytes 
and fibroblasts in skin and thereby their specific properties in this regard are 
underestimated when using full-skin biopsies. 
The data presented in Paper IV suggests that cultured melanocytes are acti-
ve, motile and intensively proliferating cells. For instance, the high expression 
level of histone genes in melanocytes refers to intensive DNA synthesis as 
histones are responsible for nucleosome structure and proper DNA wrapping 
(Alberts et al., 2008). The kinesin genes upregulated in melanocytes are related 
to cell movements and intracellular trafficking, including chromosome and 
centrosome positioning during mitosis (Verhey et al., 2011). Calcium-binding 
proteins are responsible for numerous cellular processes, e.g. cell cycle regu-
lation and differentiation, but have also been suggested to have tumor suppres-
sor functions and are highly expressed in cells with stem cell properties (Auge 
et al., 2005, Chen et al., 2014). All these findings correlate well with the high 
proliferative activity we saw during the melanocytes cultivation process. 
Previous studies have pointed out the role of melanocytes as pigment- 
producing cells in the skin. The gene expression profile of melanocytes has 
been compared to other normal skin cells, but also to pathologic melanoma cells 
(Lee et al., 2013, Hoek et al., 2004). We confirmed the high expression level of 
previously identified melanocyte-specific genes, such as DCT, TYR, KIT, 
EDNRB, MITF, and TYRP1, in melanocytes (Lee et al., 2013). DCT, TYR and 
TYRP1 encode enzymes acting in the melanin synthesis pathway (Cichorek et 
al., 2013). EDNRB and MITF are crucial for melanoblast proliferation and KIT 
is needed for the differentiation of melanoblasts into TYR-positive melanocytes 
(Lee et al., 2013, Hoek et al., 2004). We also showed that MC1R, PLA1A, 
NPM2 are uniquely expressed in melanocytes, but not in keratinocytes or 
fibroblasts (Table 4) corroborating previously published data (Roberts et al., 
2006). MC1R, a receptor for melanocyte-stimulating hormones and adreno-
corticotropic hormone, is involved in regulating the pigmentation of the skin 
and hair. PLA1A and NPM2 have both been shown to be essential in melanoma 
progression (Liu et al., 2009, Koga et al., 2009). In agreement with previous 
studies (Lee et al., 2013, Hoek et al., 2004) the expression of ABCC2, DNAJA1, 
GPR143, MLANA, OCA2, QPCT, RRAGD, TBC1D7 and GPR137B was 
detected at a higher level in melanocytes compared to keratinocytes and 
fibroblasts. The majority of these genes are also related to the melanogenesis 
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pathway, controlling the growth and maturation of melanosomes. Additionally, 
the genes are involved in melanoma progression (Du et al., 2003, Lee et al., 
1995, Gillis, 2006, de Souza et al., 2012). 
We showed that a number of genes were specifically upregulated in cultured 
melanocytes. The exact role of these genes in studied cell types is unclear, but 
based on the existing biological data they can be classified into the following 
categories: tumorigenesis, inflammation and stemness-related processes. 
 
 
2.1. Tumorigenesis 
Genes belonging to the pathways involved in tumor progression are more 
characteristic to melanocytes than to keratinocytes and fibroblasts. High 
expression of known and potential tumor suppressor genes such as ARL9, 
SLC22A18, DAPK1 and BEX1 could be observed in melanocytes compared to 
keratinocytes and fibroblasts (Louro et al., 2004, Chu et al., 2012, Ahmed et al., 
2010, Foltz et al., 2006). We detected also the expression of the members of a 
novel tumor suppressor family IGLON (IGLON2, IGLON 3 and IGLON4) in 
melanocytes (Chen et al., 2003). IGLON3, also known as LSAMP was pro-
minently expressed in melanocytes compared to keratinocytes and fibroblasts. A 
number of genes, which normally have a role in growth and cell division or in 
apoptosis regulation, can play a role in cancer formation (Wu et al., 2012). As 
an example, certain RING finger proteins – RNF144A, RNF157 and RNF187 – 
were specifically upregulated in melanocytes. We confirmed an increased 
expression of genes related to melanoma invasion and its metastatic potential 
(Marzook et al., 2012). 
 
 
2.2. Inflammation 
The susceptibility to malignancies is linked to the deregulation of inflammatory 
processes. Uncoordinated inflammatory response affects cancer development at 
different levels – predisposing to precanceroses, misleading the immune system, 
initiating invasion process etc. (Elinav et al., 2013). An example about the 
relation of immune response and tumorigenesis is the involvement of the family 
of tumor necrosis factors (TNFs) and their receptors in cancer formation. Being 
strongly engaged in both immune system modulation and apoptosis regulation, 
they trigger infiltration of inflammatory cells into tumor tissue (Wajant, 2009). 
The cross-regulation of TNF and interferon regulatory factors has been 
proposed recently (Cantaert et al., 2010). In line with this, the tumor necrosis 
factor receptors TNFRSF14, TNFRSF19 and interferon regulatory factors IFI6 
and IRF4 were highly expressed in melanocytes compared to keratinocytes and 
fibroblasts. Cytokines from the IL-10 family are among the key players in host 
defense mechanisms and bear both pro-inflammatory and anti-inflammatory 
roles (Burgdorf et al., 2009). In Paper II, a quantitative real-time PCR analysis 
of selected IL-10 family cytokines mRNAs indicated differential expression in 
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cultivated juvenile melanocytes relative to keratinocytes and fibroblasts. The 
data correlates well with the whole transcriptome analysis results. For example, 
IL20RA and IL20RB had significantly higher expression in keratinocytes 
compared to melanocytes. Also, IL22RA1 could be found in keratinocytes and 
not in melanocytes, whereas IL22RA2 gene was expressed in whole skin but not 
in melanocytes, keratinocytes or fibroblasts (Table 2). Among the studied IL-10 
family cytokine genes (IL10, IL19, IL20, IL22, IL24, IL26, IL28B, IL29) and 
their receptors (IL10RA, IL10RB, IL20RA, IL20RB, IL22RA1, IL22RA2, 
IL28RA), IL24 was the most prominent cytokine in melanocytes, which was 
hardly detectable in keratinocytes and fibroblasts (Table 2). 
 
 
2.3. Stemness-related processes 
Cultured melanocytes express many genes, which are characteristic of stem 
cells. Evidence shows that several pathways important in normal stem cells 
(BCL2 family genes, Notch, Sonic hedgehog and Wnt signaling pathways) may 
also act in cancer development (Reya et al., 2001, White and Zon, 2008). For 
instance, we saw an increased expression of antiapoptotic BCL2 and BCL2A1 
and stem cell factor inducer RCAN1 (Wu et al., 2013) in melanocytes when 
compared to keratinocytes, fibroblasts and whole skin. Interestingly, CD200 
was uniquely expressed in melanocytes (Table 4). CD200 has been proposed to 
be a marker of follicular stem cells, but it has been shown that cancers 
overexpressing CD200 expand and metastasize more rapidly (Rosenblum et al., 
2004). As mentioned above, the expression of S100 calcium-binding protein 
gene, which are specifically expressed in cells with stem cell properties, but 
have also shown to be prognostic markers for melanoma progression (Auge et 
al., 2005), was increased in melanocytes. Tumor cells and stem cells both 
possess self-renewal capacity – they have extensive proliferative potential and 
stem cells are often targets for malignant genetic transformations (Reya et al., 
2001). These stem-cell-like properties have brought forth melanocytes as a 
potential source for induced pluripotent stem cells (iPSCs) (Utikal et al., 2009). 
The data presented in Paper IV provided insight into the possible roles of 
melanocytes in the skin. As expected by the rapid growth in the cell culture, our 
differential gene expression and pathway analyses described melanocytes as 
cells with a high proliferative capacity in vitro compared to keratinocytes and 
fibroblasts. That might suggest they have preserved the readiness to regenerate 
and possess stem-cell-like properties to a larger extent than bulk keratinocytes 
and fibroblasts. However, these properties make melanocytes the most 
vulnerable cells in the skin and provide an explanation to their increased 
susceptibility to harmful environment agents (e.g. UV exposure) and high 
incidence rate of malignancies that originate from this cell type. On the other 
hand, the increased stem cell-like properties provide melanocytes with good 
self-renewing potential and also advocate for their use as a potential source for 
induced pluripotent stem cells for therapeutic purposes. 
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2.4. Extracellular matrix 
Extracellular matrix (ECM) is a well-organized network that provides structural 
and biochemical support to the cells. In tissue-engineered products, the cells are 
embedded into artificially created ECM. The embedded cells are expected to 
synthesize specific components of the ECM, which are characteristic to the 
particular type of the tissue and thus contribute to the formation of a natural-like 
tissue structure. As the final goal of our work is to develop an appropriate 
tissue-engineered matrix for the skin, which could mimic the architecture in the 
normal dermis, we used fibroblasts as a model system for our next set of 
experiments. In the skin, the biosynthesis and degradation of the extracellular 
matrix is mostly conducted by fibroblasts, which are the prevailing cell type in 
the dermis. The importance of fibroblasts in the regulation of ECM was 
underlined by the results of the transcriptome analysis. We found that a number 
of ECM-related genes were detectable in fibroblasts (Table 5). In addition to 
several well-characterized collagen genes, we could detect the expression of 
LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB2, LAMB3, LAMC1, 
LAMC2, which encode the alpha1, 2, 3, 4, beta1, 2, 3 and gamma 1 and 2 
subunits of laminins in fibroblasts (Table 5). Laminins are integral parts of the 
extracellular matrix being the key elements of the basement membrane (Ekblom 
et al., 2003). Meanwhile, they also act as binding molecules between cells and 
other ECM components in the dermis. For instance, LAMA1 is present mostly 
in the embryo and is not common for adult tissues (Ekblom et al., 2003). As 
pointed out earlier, we detected LAMA1 gene expression in melanocytes and in 
fibroblasts. One has to keep in mind that these cells were harvested from 
juvenile skin and were cultured in vitro. 
Nevertheless these results from the whole transcriptome analysis showed 
that fibroblasts are capable of producing an array of ECM constituents. 
Further, our preliminary results demonstrated that fibroblasts cultivated on 
cross-linked glucose-containing electrospun gelatin meshes can highly express 
laminin β1-chain protein, but also laminin α4 and α5-chain proteins to a small 
extent. In standard cell culture conditions the expression of laminin β1 and α4-
chain but not α5 chain were observable (unpublished). These results are in good 
correlation with the gene expression analysis (Table 5). 
Whole transcriptome analysis pointed out several remarkable genes and 
groups of genes that we should pay attention to in our further studies. When 
developing substitutes for skin tissue, we can evaluate changes in gene and 
protein expression after transferring cells from a monolayer culture into a three-
dimensional structure. 
 
 
3. Biocompatible surfaces 
In many cases instead of biomimicking a complicated extracellular matrix, a 
simple biocompatible surface is used for the cells. Hence it has been 
demonstrated previously, that by modifying exclusively the surface topography, 
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we can influence the morphology (including the placement of the cell body and 
spreading of the cell extensions), attachment, proliferation and growth of the 
cells (Poellmann et al., 2010, Altala et al., 2011). In Paper I, we studied the 
effect of the surface structure on the morphology and growth properties of 
primary human dermal fibroblasts. The novel sol-gel technique we used in our 
study is adaptable to a wide range of different material compositions and by its 
modification we can obtain different surface structures with a variety of 
mechanical and chemical properties. The method is extremely flexible since by 
variation of just solvent and sol concentrations we could generate dome-shape 
silica (SiO2) structures with diameters ranging from 200 nm to 10 μm on boro-
silicate inserts. 
Borosilicate glass inserts are commonly used for cell culturing. They com-
pose mainly of SiO2, B2O3, Al2O3, Na2O, K2O, ZnO and TiO2 and their 
suitability for cell culturing has been proved by numerous experiments (Altala 
et al., 2011). In tissue engineering practice the bioactive glasses are widely used 
for hard tissue culture, such as bone. The ingredients of bioglass do not differ 
significantly from borosilicate glass, composing SiO2, Na2O, CaO and P2O5 in 
specific proportions. Meanwhile the components vary – CaO can be replaced 
with MgO or CaF2, Na2O with K2O. Some B2O3, Al2O3, Ca(PO3)2 and TiO2 can 
also be added (Hollinger, 2011). The bioactive glass samples with SiO2 content 
of 60% and higher are quite inert, whereas other glass constituents, which are 
meant to enhance the mechanical properties of the material, might turn out to be 
toxic for all or some specific types of cells (Hollinger, 2011). Sol-gel method 
and the following thermal treatment frees the material from residual solvent 
traces and provides a pure material with excellent bioactivity (Gupta and 
Kumar, 2008). At the same time the method enables to easily produce surfaces 
with different topography and mechanical properties and thereby modify the 
behaviour of the cells. 
In our experiments we used domes generated by the sol-gel technique and 
which consisting of Si02. It is important to note that the surface chemistry does 
not vary between the differently patterned silica surfaces, even in the flat 
portion of the substrates. Hence the changes in cell morphology and prolife-
ration are caused by the structure of the surface and not by differences in the 
chemical composition of the materials. 
It has been shown previously that the pyramidal shape of the fibroblasts is 
indicative of cell migration (Stockton and Jacobson, 2001). When we cultivated 
the fibroblasts on the nanopatterned surfaces we found that a number of cells 
grown on S3 and S4 surfaces had lost their pyramidal or spindle shape and 
become more enlarged – characteristic to senescence fibroblasts. The reason 
why fibroblast cultures grown on S3 and S4 surfaces contained more enlarged 
and senescent cells is likely related to attachment deficit and disturbance of 
normal cytoskeleton. The inability of the cell membrane to bend between the 
domes in case of S3 decreases the contact surface between the cell and the 
nanopatterned surface which may also lead to a decrease in the number of 
anchoring points. Most of the domes present in S1 and in S2 on the other hand 
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were successfully integrated into the cell membrane due to their smaller size 
and did not markedly influence the attachment of the cell to the surface. These 
data are in good correlation with the observation that an increase in the 
distances between cell’s anchoring points results in enhanced differentiation of 
epidermal and mesenchymal stem cells (Trappmann et al., 2012). In the case of 
S4, the cell was able to spread over the domes due to the wide bending angle 
and long distance between the domes. Although this resulted in a complete 
attachment of the cells to the substrate, the presence of protrusions of S4 sur-
faces, which affect the 3D organization of the cytoplasm, affected the cells 
ability to proliferate and induced senescence. 
Our results suggest that in addition to the chemical component of extra-
cellular environment, the cells are influenced by the micro- and nanoscale 
structure of the surface. From dome size 1µm and higher the survival of the 
cells decreases, which is likely caused by the paucity on contacts between the 
cells and the surface and also by defects of cytoskeleton, which in its own turn 
leads to cellular senescence. 
 
 
4. Gelatin scaffolds modified  
by glucose-assisted thermal cross-linking 
In order to mimic the structural components of the extracellular matrix, which 
in a tissue are formed by micro- and nanoscale fibres, the artificial substrate 
should also be presented to the cells in the shape of a fibrous network. Several 
methods have been put forward for the formation of natural-like tissue 
structures including phase separation, self-assembly, surface patterning, 
wetspinning, biospinning, interfacial complexation, microfluidic spinning, 
meltspinning and electrospinning (Altala et al., 2011, Gupta and Kumar, 2008). 
Gelatin is a mixture of naturally occurring collagens and thus suits well for 
the formation of an artificial biocompatible scaffold. To give the gelatin fibres a 
shape, these need to be cross-linked. It was demonstrated that glucose could be 
used to increase the extent of collagen cross-linking (Ohan et al., 2002). 
Although gelatin nanofibres can be cross-linked by thermal treatment alone, we 
demonstrated for the first time that combining thermal treatment with cross-
linking by glucose allows us to control the extent of cross-linking to a large 
degree by varying glucose content in the gelatin fibres. 
Glucose, albeit an essential energy source, is toxic to cells when its con-
centration exceeds a certain value. This phenomenon can be observed in 
patients with diabetes, where the high blood glucose level can cause abnormal 
collagen cross-linking and thereby affect structure, mechanical properties and 
functioning of tissues (Lubec et al., 1991). Therefore, it is necessary to keep 
glucose levels in physiologically suitable range during cell culture. In our study 
we confirmed the lack of free glucose in scaffolds, since glucose is covalently 
bound to the matrix proteins. Therefore the changes in the morphology and 
numbers of cells grown on the glucose-based cross-linked scaffolds cannot be 
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explained by the influence of glucose itself, but by changes in mechanical pro-
perties. 
The morphological differences between cells on scaffolds with different 
glucose content were probably caused by variations in fibre diameter and orien-
tation (Figure 16) and mechanical properties. The increase in fibre size can be 
explained by the increasing viscosity of electrospinning solution and the fact 
that while every electrospinning solution contained 25% gelatin, it contained a 
smaller and smaller percentage of solvent as glucose was added to the solution 
When used in tissue engineering or wound healing applications, the scaffold 
should degrade over time. Before cross-linking, the scaffolds were water-
soluble. Cross-linking, however, converted the scaffolds insoluble in boiling 
water, glacial acetic acid and cell culture media. Interestingly, the scaffolds 
prepared by using 20% or higher glucose content became partially or fully 
resistant to enzymes responsible for the degradation of extracellular matrix in 
the body. These results, combined with the data obtained from FTIR analysis, 
suggest that the maximum extent of cross-linking was achieved at approxi-
mately 20% glucose. 
Although gelatin is believed to consist mainly of type I collagen the exact 
protein content of gelatin depends on the extraction method as well as the origin 
of raw material. Previous studies have shown that under the same conditions 
collagen type I had higher cross-linking capacity compared to mixtures of 
collagen types I and III. The reason for this phenomenon is related to the 
dissimilarities in primary structures and molecular organization of different 
types of collagen (Mentink et al., 2002). Protein analysis indicated a remarkable 
difference between type A and type B gelatin used in this work. Both high rate 
of additives and different protein profiles might have affected the cross-linking 
process, leading to differences in scaffold properties and cell growth. 
 
 
5. Concluding thoughts and future prospects 
Normal versus artificial condition. 2D versus 3D environment 
To define pathologic alterations, the “normal” has to be defined. The same 
applies to defining “artificial” and “natural” (“normal”) conditions. In the past 
few decades the most important method for investigating the behaviour of 
different cell types has been based on isolating and cultivating the cells. Cells 
obtained via extraction from tissue followed by multiplying in cell culture have 
been assumed to be “normal” cells. For instance in monolayer 2D cell culture, 
spindle-shape morphology is assumed to be “normal” morphological shape for 
dermal fibroblasts. These differentiated and mostly non-proliferative cells, 
extracted from tissues, have been inserted to cell culture media, supplemented 
with different nutrients and hormones and as a result start to replicate actively. 
It has been described that any manipulation with cells can cause changes in 
their functioning – the cell viability, proliferation, morphology, protein or gene 
expression etc. The smaller the change, the harder it is to interpret the effect. If 
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the factor causes changes in cell proliferation, viability or morphological 
changes, it can be measured or described relatively easily. Hence, it has been 
shown previously that even small changes in the environment surrounding cells 
might have an effect at gene expression level (Achterberg et al., 2014). In our 
gene expression study we have to take into account that gene expression could 
still be influenced by in vitro culture conditions (Neumann et al., 2010, 
Crisostomo et al., 2006). In our study this could be an issue in the case of IL10, 
IL22RA2 and IL26 (Paper II) where gene expression was observed in the whole 
skin, but was absent in the cell culture. Also, mRNA synthesis could occur in 
other cell types than in keratinocytes, melanocytes and fibroblasts. For instance, 
IL26 and a soluble receptor IL22RA2, which is considered to be stored in the 
extracellular matrix for on demand release (Schonherr and Hausser, 2000), are 
produced mainly by resident T cells (Dumoutier et al., 2001, Donnelly et al., 
2010). Although both subunits of IL22R complex and IL10RB are required to 
form the functional receptor (Table 1), IL22RA2 is able to bind alone to IL22 
(Kotenko et al., 2001). Unlike IL22RA2, which is strictly an antagonist for IL22 
activity, IL22RA1 regulates both IL22 and IL20 activity (Table 1) and its 
expression was detectable only in keratinocytes (Figure 4f). 
The same phenomenon can be seen in the gene expression pattern analysis 
(Paper IV), which describes the cultured melanocytes as highly proliferative 
cells. We have to consider that the high proliferation rate is characteristic only 
to artificially cultured melanocytes and does not reflect the actual situation in 
vivo. The cell culture conditions include less cell-cell contacts and a high level 
of growth factors reminiscent of active regenerative state (like in the case of 
wound healing). The same precautions should be applied to cultivated keratino-
cytes and fibroblasts we analyzed in our study. Thus the analysis of gene 
expression pattern of cultured cells does not reflect the homeostatic state of the 
cells in a tissue but rather is expected to describe their response to an injury. On 
the other hand, a number of well-characterized cell type-specific genes could be 
readily identified from each cell population analyzed, suggesting that the low-
passage cultured cells have well retained their identity. Since the cell culture has 
remained as a gold standard for obtaining sufficient amount of relatively homo-
genous cell populations for tissue engineering and toxicity testing, knowing the 
characteristic properties of cells in culture is instrumental for their further use in 
ex-vivo applications. 
The potential technique, which eliminates influence caused by cell culture 
conditions is the laser capture microdissection (LCM). Although the LCM is an 
excellent tool for the isolation of groups of cells in the case of melanocytes, 
which are present as single cells located in close contact with both keratinocytes 
and fibroblasts, the use of LCM would result in isolation of the melanocytes and 
adjacent cells, which would contaminate the sample. Additionally, to obtain a 
sufficient amount of cells, in vitro cell cultivation is still necessary. The results 
of gene expression analysis suggest possible roles for keratinocytes, 
melanocytes and fibroblasts in the skin, however, further studies are needed to 
find out, whether the expression level of genes reflects also protein levels and 
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functionality of the cells. The current understanding about the functions of cells 
in the tissue are based largely on studies of cells cultured on flat, two-
dimensional (2D) plastic or glass substrates. However, in the body, cells are 
embedded within a tissue-specific three-dimensional scaffold (3D) – extra-
cellular matrix. 
Some cell types lose the characteristic markers of differentiation and become 
actively proliferative when grown on 2D surfaces. Some cell types are able to 
regain partially or entirely their properties when transferred into 3D structure, 
which mimics their original tissue (Baker and Chen, 2012). This leads to the 
conclusion that 2D cell culture recapitulates active regeneration of wound 
healing processes. The intermediate proliferating phase is necessary to obtain 
the number of cells needed for tissue reconstruction, however the most 
important task is to achieve the natural properties, the cells have in tissue by 
transferring and the multiplied cells back into a physiological 3D culture. One 
has to make sure that the matrix used in the 3D culture recapitulates the 
properties of the natural matrix of the particular tissue and sustains the specific 
properties of the embedded cells. Cell adhesion, mechanical forces and 
permeability to soluble factors are important factors, which influence cells in a 
3D system. The multiplicity of adhesion sites between the cells and the 
extracellular matrix in a 3D system, compared to flat 2D substrate, lead to the 
changes in cell morphology and intracellular signaling. In our study we 
demonstrated that gelatin scaffolds modified by glucose-assisted thermal cross-
linking are promising material for skin tissue engineering due to its nontoxic 
components and biocompatibility. However, the matrices designed by us 
behaved more like 2D rather than 3D structures for the cells, therefore our 
future studies will concentrate on the development of three-dimensionality of 
the material to facilitate the entrance of the skin cells into the matrix. For that 
purpose, the physical properties, such as porosity, stiffness, elasticity etc. of the 
scaffolds should be measured to determine tissue-specific parameters needed for 
the growth of the skin cells. 
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CONCLUSIONS 
1. Juvenile skin cells, due to their excellent proliferative capacity, are mostly 
used for tissue-engineered products. We aimed to understand cell behaviour 
in an artificial environment, especially pro- and anti-inflammatory markers, 
which play a role in tissue rejection process. Our in vitro analysis showed 
that the production of IL-10 family cytokine and their receptors is cell-
specific, which helps to explain the roles of keratinocytes, melanocytes and 
fibroblasts in the inflammatory system. 
2. We identified a number of genes and pathways, which are characteristic for 
melanocytes, keratinocytes and fibroblasts. We also demonstrated the 
difference in gene expression patterns between skin cell cultures and the 
whole skin. The data presented provide an insight into the various possible 
roles of melanocytes, keratinocytes and fibroblasts in the skin. We can 
conclude that the analysis of gene expression pattern of cultured cells does 
not reflect the homeostatic state of the cells in a tissue but is rather expected 
to describe their response to injury. On the other hand since the cell culture 
has remained as a gold standard for obtaining sufficient amount of relatively 
homogenous cell populations for tissue engineering and toxicity testing, 
knowing the characteristic properties of cells in culture is instrumental for 
their further use in ex-vivo applications. 
3. Sol-gel based method enables to design surfaces with various structural, 
mechanical and chemical properties, all of which are relevant in producing 
biocompatible, bioactive or biomimicking materials. We applied a novel 
sol–gel phase separation-based method for the preparation of micro- and 
nanopatterned silica surfaces with round nano- and microscale domes from 
simple TEOS-alcohol sol compositions. We saw that microscale surface 
(dome size less than 1 µm) with high density of domes (more than 240,000 
domes per mm2) provides a sufficient number of attachment sites for dermal 
fibroblasts without causing fatal disturbances into the cytoskeleton architec-
ture, thus being a potential biocompatible material with good potential for 
tissue-engineering purpose. 
4. Glucose can be used as a natural non-toxic cross-linking agent, which 
allows to generate biocompatible electrospun fibrous gelatin scaffolds for 
skin cells. Rising glucose content up to 20%, the extent of cross-linking of 
gelatin scaffolds increases linearly. From glucose content about 20% and 
higher, scaffold’s fibres become resistant to enzymatic digestion, suggesting 
their inappropriateness for biodegradable devices. Cross-linked scaffolds 
obtained at up to 15% glucose content supported fibroblast growth and cell–
scaffold interaction. 
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SUMMARY IN ESTONIAN 
Mikrokeskkonna mõju naharakkudele 
Vajadus nahakoe siirdamiste järele on maailmas üha suurenemas. Biotehno-
loogilisel teel saadud nahakoest soovitakse leida abi nii suurte põletuste, krooni-
liste haavandite kui ka kaasasündinud ja omandatud nahadefektide ravis. Füsio-
loogilisele nahale võimalikult sarnase nahaanaloogi valmistamiseks on vajalik 
nii funktsioonivõimeliste naharakkude kui rakke ümbritseva tugisüseemi 
olemasolu. 
Inimese naha rakulise komponendi moodustavad peamiselt epidermises 
paiknevad keratinotsüüdid ja melanotsüüdid ning dermises paiknevad fibro-
blastid. Kõigil kolmel rakutüübil on oma spetsiifilised ülesanded nahakoes: 
tihedalt mitmekihilise struktuurina paiknevad keratinotsüüdid tagavad organis-
mile esmase kaitse väliste keskkonnamõjude, sealhulgas patogeenide eest; pig-
mendisünteesi eest vastutavad melanotsüüdid; ning fibroblastid on peamisteks 
rakuväliste valkude tootjateks. Selleks et naharakud oma spetsiifilisi funkt-
sioone täita saaksid, on vajalik koele omase tugisüsteemi – rakuvälise maatriksi 
olemasolu. Rakuväline maatriks koosneb paljudest valkudest ning polüsahha-
riididest, mis on omavahel põimunud võrgustikuks. Varasemates uuringutes on 
näidatud, et ka väikseimad muutused rakke ümbritsevas keskkonnas mõjutavad 
oluliselt rakkude toimimist, seega vajavad rakud tehiskudedes oma funktsioo-
nide täitmiseks füsioloogilisele võimalikult sarnast keskkonda. Ülesandeid, 
mida naharakud peavad täitma, on kordades rohkem kui ülalmainitud ning 
paljud neist pole veel teada või vajavad täiendavaid uuringuid. 
Väga oluline on rakkude õige funktsioneerimine tagada tehiskudede arenda-
misel. Meie teadustöö laiemaks eesmärgiks on töötada välja nahale iseloomu-
like keemiliste ja füüsikaliste omadustega struktuurne materjal, mis võimalikult 
hästi imiteeriks füsioloogilist rakuvälist maatriksit. 
Käeolev doktoritöö hõlmab nelja artiklit, milles uurisime naharakkude geeni-
ekspressiooni mustrite erinevusi ning rakuvälise nano- ja mikrokeskkonna muu-
tuste mõju rakkude morfoloogiale ja molekulaarsetele omadustele. 
Esimene artikkel kirjeldab interleukiin-10 (IL-10) perekonna tsütokiinide 
(IL10, IL19, IL20, IL22, IL24, IL26, IL28B, IL29) ja nende retseptorite (IL10RA, 
IL10RB, IL20RA, IL20RB, IL22RA1, IL22RA2, IL28RA) geeniekspressioonide 
erinevusi keratinotsüütide, melanotsüütide ja fibroblastide rakukultuurides, 
kasutades selleks qRT-PCR meetodit. IL-10 perekonda kuuluvad nii põletikku 
soodustavad kui ka põletikuvastased interleukiinid. Lisaks on selle perekonna 
tsütokiinidel oluline roll nii haavade paranemisel kui ka doonorkudede ära-
tõukereaktsioonide väljakujunemisel. Kuna koedisainis kasutatakse sageli just 
juveniilseid rakke, siis üheks meie eesmärgiks oli hinnata laste nahakoest eral-
datud rakkude põletikulist potentsiaali. Uurisime geeniekspressiooni ka terves 
nahakoes ning leidsime, et IL-10 perekonna tsütokiinid ning nende retseptorid 
on erinevalt ekspresseerunud laste ja täiskasvanute nahas, mis võib olla tingitud 
lapseea immuunsüsteemi ebaküpsusest ning mida peab arvesse võtma, kui 
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kasutame juveniilseid rakke ka täiskasvanud inimestele mõeldud tehiskudede 
arendamisel. 
Teine artikkel kirjeldab keratinotsüütide, melanotsüütide ja fibroblastide 
geeniekspressiooni mustrite erinevusi kogu transkriptoomi tasemel. Transkrip-
toomi sekveneerimiseks kasutasime SOLiD 5500xl platformi. Lisaks rakutüübi 
spetsiifilistele geeniekspressiooni mustritele nägime, et kultuuri viidud rakku-
des, eeskätt just melanotsüütides, oli ekspresseerunud mitmeid rakkude prolife-
ratsiooni eest vastutavaid geene. Selline leid viitab asjaolule, et rakukultuur 
kirjeldab pigem koe vigastuse järgset seisundit ning ei peegelda täpselt rakkude 
homöostaatilist seisundit. Samas leidsime, et varasemalt põhjalikult kirjeldatud 
rakuspetsiifiliste geenide ekspressiooni (nt. melanotsüütide pigmendisünteesi 
radadega seotud geenid) kultiveerimine oluliselt ei muutnud, kuna uuringus 
kasutasime ainult minimaalselt ümberkülvatud (2 – 3x) rakke. 
Kolmanda artikli eesmärgiks oli hinnata uudsel sool-geel meetodil valmis-
tatud Si02 nano- ja mikrostruktuursete pindade biosobivust. Selleks kasvatasime 
erineva struktuursusega pindadel nahakoest eraldatud fibroblaste. Uuringu 
tulemustest selgus, et rakkude kasv ja paljunemine pindadel sõltub suuresti 
nano- ja mikrostruktuuride paigutuse tihedusest, samuti struktuuride läbi-
mõõdust. Uuritud pinnad, mille struktuuride läbimõõt ei ületanud 1 µm ja 
struktuuride tihedus oli üle 240,000/mm2, tagasid rakkudele piisavalt adhesiooni 
punkte ning ei häirinud tsütoskeleti ülesehitust ning toetasid rakkude kasvu ja 
paljunemist. Seetõttu on nimetatud pinnad potentsiaalselt sobilikud koe-
tehnoloogiates kasutamiseks. 
Neljas artikkel keskendub naturaalse biopolümeeri – želatiini – kasutamis-
võimaluste välja selgitamisele rakuvälise maatriksi arendamisel. Uurisime 
elektroformeeritud ning erineva kontsentratsiooniga glükoosi ning temperatuuri 
koosmõjul ristsidestatud želatiinmattide bioloogilisi omadusi – biolagunevust, 
neil kasvatatud fibroblastide proliferatsiooni, morfoloogiat ja paiknemist. 
Uuringu tulemusena selgus, et kuni 15% glükoosi abil valmistatud maatriksid 
toetasid rakkude kasvu ning paljunemist. Üle 20% glükoosi abil ristsideststud 
želatiinmatid enam rakuvälise maatriksi valke lõhustavate ensüümide (kollage-
naas II, IV ja trüpsiin) toimel ei lagunenud, samuti oli näha neil pindadel rakku-
de kasvu pidurdumine. 
Käesoleva töö raames näitasime, et rakuvälise keskkonna omadused mõju-
tavad oluliselt rakkude kasvu, paljunemist ning morfoloogiat. Arendasime välja 
erinevad potentsiaalsed biosobivad materjalid koeanaloogide valmistamiseks. 
Edaspidises töös keskendume biomaterjalide omaduste – poorsus, elastsus, 
venitatavus jne. mõõtmistele ning selle põhjal materjalide edasi arendamistele, 
et saavutada füsioloogilisele nahale võimalikult sarnaselt funktsioneeriv naha-
analoog. 
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